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 Abstract 
Alzheimer’s disease (AD) is a progressive and fatal neurodegenerative 
disorder that slowly destroys neurons and cognitive abilities. Familial AD 
is linked to mutations in a specific set of genes, most often in the genes 
encoding amyloid precursor protein (APP) and the presenilins 1 and 2 
(PS1, PS2). Several studies have demonstrated that the missense 
mutations in PS genes perturb endoplasmic reticulum (ER) Ca2+ 
homeostasis. In vitro, such perturbations result in an increase in Ca2+ 
levels within the ER Ca2+ stores and in a reduction of the capacitative 
Ca2+ entry. However, little is known about the contribution of intracellular 
Ca2+ stores to network-driven neuronal activity in vivo and their role for 
AD-related neuronal dysfunction.  
We studied in vivo functional properties of intracellular Ca2+ stores in 
cortical neurons by using two-photon Ca2+ imaging in 10-14-month-old 
transgenic APPswe/PS1 G384A (AD), PS1 G384A (PS45), and age-
matched wild type (WT) mice. We monitored spontaneous neuronal 
activity of layer 2/3 neurons in the frontal cortex and classified cells as 
silent, normal or hyperactive based on the frequency of their Ca2+ 
transients [Busche et al., 2008]. Compared with young adult animals, we 
observed a robust increase in the fraction of hyperactive cells in aged 
mice from all three strains, indicating an aging-mediated increase in 
neuronal hyperactivity. We next investigated Ca2+ release from 
intracellular Ca2+ stores in the intact AD and WT brain using an agonist 
of ryanodine receptors (RyRs) caffeine. We discovered exacerbated 
caffeine-induced Ca2+ signals in AD compared to WT mice as suggested 
by a prolonged decay phase of caffeine-induced Ca2+ transients and an 
increase in unitary caffeine-evoked responses. Additionally, we found 
that N-methyl-D-aspartate receptor (NMDAR)-mediated Ca2+ entry 
further triggers Ca2+ release from intracellular Ca2+ stores in AD mice. 
Interestingly, these responses are most pronounced in hyperactive cells, 
indicating a stronger overfilling of intracellular Ca2+ stores in hyperactive 
relative to silent and normal cells.     
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To decipher the contribution of Ca2+ release from intracellular Ca2+ 
stores to network-driven spontaneous Ca2+ transients, the stores were 
emptied by a reversible inhibitor of SERCA pumps cyclopiazonic acid 
(CPA). Topical CPA application normalizes pathological activity patterns 
by reducing neuronal hyperactivity in AD but not in WT mice. We further 
investigated the sole effect of PS1 G384A mutation on neuronal network 
activity and revealed for the first time that PS1 G384A mutation alone is 
sufficient to mediate neuronal hyperactivity in PS45 mice. Such 
perturbation occurs independently of mutant gene dosage, plaques 
formation, and inflammation. Furthermore, this phenomenon is already 
present in young adult animals (6-7 months old). Interestingly, store 
depletion reduces hyperactivity in PS45 mice similar to AD mice, 
indicating that the pathological activity patterns in both mouse strains 
are related to the dysfunctional of intracellular Ca2+ stores. We further 
investigated the response of presynaptic Ca2+ signals in PS45 mice to a 
depletion of intracellular Ca2+ stores. By imaging axonal boutons 
originating from layer 5/6 neurons, we found that emptying of 
intracellular Ca2+ stores affects the frequency but not the pattern of 
spontaneous Ca2+ transients in axonal boutons. Next, we tested the 
contribution of presynaptic glutamate release on postsynaptic 
spontaneous neuronal activity using the activity-dependent irreversible 
NMDAR blocker MK-801. Results obtained in PS45 mice showed that 
hyperactive cells exhibit higher open probability of postsynaptic NMDA 
receptors compared to normal cells, which is likely caused by increased 
presynaptic glutamate release. When testing the role of intracellular 
Ca2+ stores for postsynaptic dendritic Ca2+ signals in PS45 mice, we 
found that the stores are involved in controlling the frequency and 
synchronization of spontaneous dendritic Ca2+ transients in different 
dendritic branches.  
Taken together, our data demonstrate that aging aggravates neuronal 
hyperactivity. Additionally, in vivo function of ryanodine-sensitive 
intracellular Ca2+ stores is altered in amyloid depositing mice as 
suggested by exaggerated caffeine-induced Ca2+ signals. Furthermore, 
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intracellular Ca2+ stores are critically involved in controlling the network-
driven spontaneous Ca2+ transients in AD mice. This involvement has 
both pre- and postsynaptic components and is caused by the presence 
of mutated presenilin 1 protein. Our findings pave the way for the 
development of new therapeutic strategies for AD patients based on 
normalizing Ca2+ release from the intracellular Ca2+ stores. 
 
Zusammenfassung 
Morbus Alzheimer (Alzheimer’s disease = AD) ist eine fortschreitende 
neurodegenerative Erkrankung, welche zu einer langsamen 
Degeneration von Neuronen und einem Verlust kognitiver Fähigkeiten 
führt. Die familiäre Form der Erkrankung lässt sich auf vor allem auf 
Mutationen in den Genen für das Amyloid Vorläufer Protein (amyloid 
precursor protein = APP) oder Präsenilin 1 bzw. Präsenilin 2 (PS1, PS2) 
zurückführen. Verschiedene Studien zeigen, dass Mutationen in PS1 
bzw. PS2 zu Störungen der intrazellulären Ca2+-Homöostase führen, 
welche vorrangig das Endoplasmatische Retikulum (ER) betreffen. In 
vitro resultieren diese beispielsweise in einem Anstieg der Ca2+-
Beladung des ER und einer Reduktion des kapazitiven Ca2+-Einstroms 
über die Plasmamembran. Auf welche Art und Weise intrazelluläre Ca2+-
Speicher die neuronale Netzwerkaktivität in vivo beeinflussen und 
welche Rolle sie für AD-assoziierte neuronale Fehlfunktionen spielen ist 
bisher unklar. 
In dieser Arbeit untersuchten wir die funktionellen Eigenschaften 
intrazellulärer Ca2+-Speicher in kortikalen Neuronen mittels in vivo Zwei-
Photonen-Mikroskopie in 10-14 Monate alten transgenen APPswe/PS1 
G384A (AD), PS1 G384A (PS45) und gleichaltrigen Wildtyp (WT) 
Mäusen. Zunächst ermittelten wir die spontane Aktivität von  Schicht 2/3 
Neuronen im frontalen Kortex und klassifizierten die einzelnen Zellen 
entsprechend der Häufigkeit ihrer Ca2+-Transienten als ruhig, normal 
oder hyperaktiv [Busche et al., 2008]. Bestimmt man die Anteile dieser 
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drei Kategorien innerhalb der Zellpopulation, lässt sich im Vergleich zu 
jüngeren adulten Tieren ein deutlicher Anstieg des Anteils hyperaktiver 
Neuronen nachweisen. Dieser altersvermittelte Anstieg neuronaler 
Aktivität war in allen drei untersuchten Mausstämmen zu beobachten. 
Anschließend untersuchten wir die Koffein-evozierte Ca2+-Freisetzung 
aus neuronalen intrazellulären Ca2+-Speichern im intakten Gehirn von 
WT und AD Mäusen nach Stimulation von Ryanodinrezeptoren (RyR). 
Die speichervermittelten Ca2+-Signale in AD Mäusen waren im Vergleich 
zu denen in WT Tieren verstärkt. Darüber hinaus zeigten diese 
Versuche, dass der N-methyl-D-aspartat Rezeptor (NMDAR)-vermittelte 
Ca2+-Einstrom über die Plasmamembran in vivo eine Ca2+-induzierte 
Ca2+-Freisetzung aus den intrazellulären Ca2+-Speichern hervorruft. 
Interessanterweise war dieser Effekt in hyperaktiven Neuronen stärker 
als in normalen Neuronen, was auf eine stärkere Beladung der 
intrazellulären Ca2+-Speicher dieser Zellen schließen lässt.  
Um die Bedeutung der intrazellulären Ca2+-Speicher für die spontane 
Netzwerkaktivität von kortikalen Neuronen zu charakterisieren, wurden 
die Speicher durch eine reversible Blockade der SERCA Pumpe mittels 
Cyclopiazonsäure (CPA) entleert. Badapplikation von CPA normalisierte 
die pathologische Netzwerkaktivität selektiv in AD Mäusen, ohne die 
Aktivität in WT Mäusen zu verändern. Um herauszufinden, ob eine 
Mutation des PS-Gens ausreichend ist, um die erhöhte Netzwerkaktivität 
auszulösen, untersuchten wir auch Mäuse, welche lediglich die mutierte 
Variante des PS1 (G384A) exprimieren. Diese Versuche zeigten, dass 
das Vorhandensein dieser PS1-Mutation ausreicht, um eine neuronale 
Hyperaktivität auszulösen. Dieser Effekt ist unabhängig von der 
Gendosis, Amyloidablagerungen und Entzündungsprozessen. 
Außerdem lässt sich das Phänomen bereits in jungen adulten Tieren (6-
7 Monate) nachweisen. Interessanterweise reduzierte eine Entleerung 
der intrazellulären Ca2+-Speicher die neuronale Hyperaktivität in PS45 
Mäusen in der gleichen Weise wie in AD Mäusen. Daraus lässt sich 
schlussfolgern, dass die beobachteten pathologischen Aktivitätsmuster 
in transgenen Mäusen auf funktionelle Veränderungen intrazellulärer 
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Ca2+-Speicher zurückzuführen sind. Als nächstes untersuchten wir die 
präsynaptische Ca2+-Signalgebung während einer Entleerung 
intrazellulärer Ca2+-Speicher in PS45 Mäusen. Hierzu wurden Neuronen 
der kortikalen Schichten 5 und 6 mit einem Ca2+-Sensor markiert und 
deren Axonterminalen in oberflächlichen kortikalen Schichten 
untersucht. Unsere Ergebnisse zeigen, dass intrazelluläre Ca2+-
Speicher die Frequenz spontaner Ca2+-Transienten in Axonterminalen 
modulieren, jedoch keinen Einfluss auf das Muster der Ca2+-Transienten 
ausüben. Außerdem untersuchten wir den Einfluss der präsynaptischen 
Glutamatfreisetzung auf die postsynaptische Aktivität unter Verwendung 
des aktivitätsabhängigen irreversiblen NMDAR Inhibitors MK-801 in 
PS45 Mäusen. Hyperaktive Zellen wiesen im Vergleich zu normalen 
Zellen eine höhere Offenwahrscheinlichkeit postsynaptischer NDMA 
Rezeptoren auf, was sich vermutlich auf eine gesteigerte 
präsynaptische Glutamatfreisetzung zurückführen lässt. Anschließend 
untersuchten wir die Rolle der intrazellulären Ca2+-Speicher für die Ca2+-
Signalgebung in postsynaptischen Dornfortsätzen in PS45 Mäusen. Die 
Ergebnisse lassen darauf schließen, dass intrazelluläre Ca2+-Speicher in 
diesem Kompartiment sowohl die Frequenz als auch die 
Synchronisation spontaner Ca2+-Transienten kontrollieren. 
Die vorliegende Arbeit zeigt, dass fortschreitendes Alter eine Steigerung 
der neuronalen Hyperaktivität hervorruft. In Mäusen mit 
Amyloidablagerungen ist außerdem die in vivo Funktion intrazellulärer 
Ca2+-Speicher verändert, wie die Steigerung Koffein-vermittelter 
somatischer Ca2+-Signale beweist. Intrazelluläre Ca2+-Speicher 
kontrollieren die Frequenz netzwerkgetriebener spontaner Ca2+-
Transienten in AD und PS45 Mäusen. Unsere Ergebnisse legen den 
Grundstein für die Entwicklung neuer Behandlungskonzepte für AD-
Patienten basierend auf einer Normalisierung der Ca2+-Freisetzung aus 
intrazellulären Ca2+-Speichern.   
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1.1 Alzheimer’s disease 
Alzheimer’s disease (AD) is an age-related neurodegenerative disorder 
representing a major public health problem. AD can be classified into 
two categories: the sporadic and the familial form of the disease. 
Sporadic AD (SAD) is the most common form. Its prevalence increases 
with advancing age from 1% at 65-70 years to 30% after the age of 85. 
It is characterized by moderate to extreme severity and a late age of 
onset [Mayeux R, 2003; Mayeux and Stern, 2012]. Familial AD (FAD) 
represents some 5-10% of all AD cases. FAD is linked to mutations in a 
specific set of genes, most often in the genes encoding amyloid 
precursor protein (APP) and the presenilins 1 and 2 (PS1 and PS2, 
respectively) [Tabaton and Tamagno, 2007; Bertram and Tanzi, 2008]. 
APP is a receptor-like type I glycoprotein, with a single membrane-
spanning domain, a large extracellular N-terminus, and a shorter C-
terminus [Selkoe, 2004]. PSs are polytopic membrane proteins that 
harbor the catalytic site of the -secretase complex, which mediates the 
intramembranous cleavage of many type I membrane proteins, including 
APP and Notch [De Strooper et al., 2012; Ho and Shen, 2011]. In 
addition to PS, nicastrin, anterior pharynx defective 1, and presenilin 
enhancer 2 are required for the activity of the -secretase complex 
[Takasugi et al., 2003].  
The histological hallmarks of SAD and FAD are the presence of 
extracellular deposits termed senile plaques and intracellular 
neurofibrillary tangles (NFTs) [Brion, 1998]. The major component of 
senile plaques is β-amyloid (Aβ) protein, which is produced by 
amyloidogenic processing of APP involving two sequential cleavage 
steps by the - and - secretase. - secretase cleavage of APP 
generates the secreted derivative, sAPP-, and -C-terminal fragment 
(-CTF). The latter is subsequently cleaved by - secretase, yielding 
Aβ40 and Aβ42. Alternative cleavage of APP by - secretase generates 
sAPP- and -CTF, precluding Aβ formation. Aβ40 and Aβ42 are the 
most common forms of Aβ, where the Aβ42 peptide is more prone to 
aggregate and to form soluble dimers, oligomers, protofibrills and 
eventually insoluble plaques [Tabaton and Tamagno, 2007; Ballard et 
al., 2011]. Recent studies indicate that Aβ is one of the main vicious 
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species in AD. It was implicated in production of reactive oxygen 
species, induction and release of proinflammatory cytokines, induction 
of endoplasmic reticulum stress, and an abnormal increase of the 
intracellular calcium level ([Ca2+]i) [Berridge, 2010; Hermes et al., 2010; 
Kuchibhotla et al., 2008]. Another histopathological feature of AD is the 
deposition of NFTs within neurons. NFTs consist of intracellular fibrillar 
aggregates of hyperphosphorylated forms of the microbule-associated 
protein tau. Under physiological conditions, normal tau protein interacts 
with tubulin and promotes its assembly into microtubules. Binding of tau 
protein to the microtubules is maintained by the phosphorylation of tau 
[Goedert et al., 2006; Kolarova et al., 2012]. In AD, tau exhibits an 
abnormal hyperphosphorylation and dissociates from microtubules. 
Abnormal tau redistributes from the axonal compartment to 
somatodendritic compartments and aggregates in the form of NFTs 
[Kolarova et al., 2012; Wang and Mandelkow, 2016]. 
 
1.2 Control of neuronal Ca2+ homeostasis  
Ca2+ is an essential intracellular second messenger in mammalian 
neurons that contributes to several mechanisms, for example the 
modulation of membrane excitability, gene expression, metabolism, 
exocytosis, neurotransmission, reactive oxygen/nitrogen species 
formation, and apoptosis/necrosis [Supnet and Bezprozvanny, 2010; 
Grienberger and Konnerth, 2012]. Ca2+ homeostasis is attained by 
functional coupling between multiple Ca2+ channels, exchangers, and 
protein buffers. At the resting state, cytosolic Ca2+ levels are maintained 
between 30-100 nM and they rise transiently after activation. Activation 
of neurons is associated with Ca2+ influx through the plasma membrane 
(PM) and/or release from the intracellular stores, mostly the 
endoplasmic reticulum (ER). The Ca2+- permeable channels localized in 
the neuronal PM can be divided into voltage-gated Ca2+ channels 
(VGCC), ligand-gated Ca2+ channels, e.g. N-methyl-D-aspartate 
(NMDA) receptors and store-operated Ca2+ entry (SOCE) channels 
[Hermes et al., 2010; Grienberger and Konnerth, 2012] (Figure 1). 
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Ca2+ can also be released from the intracellular stores of ER via two 
kinds of channels localized in the ER membrane, namely inositol 
trisphosphate receptor (IP3R) and ryanodine receptor (RyR). The IP3R is 
activated by the intracellular production of inositol 1,4,5-trisphosphate 
(IP3), which is produced following activation of metabotropic receptors 
coupled to phospholipase C (PLC). PLC hydrolyzes a membrane 
phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), to produce 
the intracellular messengers diacylglycerol (DAG) and IP3. The 
interaction between IP3 and IP3R causes a rapid efflux of Ca2+ from the 
ER and an increase of free Ca2+ in the cytosol [Berridge et al., 2003; 
Phillis and O’Regen, 2004; Mak and Foskett, 2015]. RyR is activated by 
the elevation of cytosolic Ca2+, a process referred to as Ca2+-induced 
Ca2+ release (CICR), which contributes, for example, to the amplification 
of the Ca2+ signals caused by activation of IP3R or by a transmembrane 
Ca2+ entry [Berridge, 1998; Sandler and Barbara, 1999]. In the resting 
neurons the level of Ca2+ in the ER is approximately 1000 times higher 
than in the cytosol [Bojarski et al., 2008]. Such a tremendous 
concentration gradient is built up by the sarcoplasmic / endoplasmic 
Ca2+-ATPase (SERCA) pump localized within the ER membrane. 
SERCA pump transports Ca2+ against its electrochemical gradient from 
the cytosol to the ER lumen via ATPase hydrolysis [Stutzmann and 
Mattson, 2011]. Additionally, the filling state of ER is modulated by 
SOCE (store-operated Ca2+ entry), a process activated upon depletion 
of the ER stores. The known proteins involved in this process are 
sensors of Ca2+ levels in the ER, including stromal interaction molecule 
1 and 2 (STIM1 and STIM2, respectively) [Roos et al., 2005, Liou et al., 
2005], and the Ca2+ channel-forming protein Orai in the PM [Feske et 
al., 2006; Zhang et al., 2006]. Upon depletion of ER Ca2+ stores, STIMs 
are activated and translocated by diffusion into ER-PM junctions, where 
they interact with the PM and activate Orai1 Ca2+ entry channels which 
lead to re-filling of the intracellular Ca2+ stores [Liou et al., 2007]. 
In addition, Ca2+ is pumped out of the cell by a plasma membrane Ca2+- 
ATPase (PMCA) and a Na+/Ca2+ exchanger (NCX). PMCA utilizes 
energy from ATP hydrolysis to transfer Ca2+ from the cytosol into the 
extracellular space [Strehler et al., 2007]. The main regulator of PMCA 
function is Ca2+-calmodulin (Ca2+-CaM). PMCA has an extended C-
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terminal tail which forms an autoinhibitory domain. Binding of Ca2+-CaM 
to this tail relieves the inhibition, providing a mechanism for regulation of 
PMCA activity by the cytosolic Ca2+ concentration [Zaidi et al., 2015]. 
NCX is a bi-directional membrane ion transporter. Using the energy of 
the Na+ gradient this transporter produces an electrogenic exchange of 
three Na+ for one Ca2+. Under normal physiological conditions, Na+ is 
transported into the cell and Ca2+ is extruded from the cytoplasm 
(termed Ca2+ exit mode) [Annunziato et al, 2004; Shenoda, 2015]. 
Furthermore, Ca2+ binding proteins such as parvalbumin, calbindin-
D28k, or calretinin, determine the dynamics of free Ca2+ inside neurons 
[Ghosh and Greenberg, 1995; Berridge et al., 2003; Schwaller, 2010]. 
Mitochondria also play an important role in regulating neuronal Ca2+ 
signaling by utilizing potent mitochondrial Ca2+ uptake mechanisms. The 
primary transporter mechanism for cytosolic Ca2+ across the outer 
mitochondrial membrane is opening of voltage-dependent anion 
channels [Rizzuto et al., 2012]. Mitochondria accumulate Ca2+ in the 
matrix via an electrogenic mitochondrial Ca2+ uniporter which acts to 
equilibrate Ca2+ according the electrochemical gradient generated by the 
respiratory chain. The extrusion of Ca2+ from the mitochondrial matrix to 
the cytosol is mediated by mitochondrial Na+/Ca2+ exchanger and 
H+/Ca2+ exchanger [Celsi et al., 2009; Giorgi et al., 2012; Grienberger 
and Konnerth, 2012]. Ca2+ uptake into mitochondria plays an important 
role in neuronal physiology by stimulating mitochondrial metabolism and 
increasing mitochondrial energy production [Bezprozvanny and Mattson, 
2008]. 
 
1.3 ER in neurons 
The ER is an extensive network of interconnected membrane tubuli 
spread throughout the cytosol. The general structure of the ER can be 
divided into three domains: i) the nuclear envelope, ii) the ribosome-
bound rough ER, iii) the ribosome-free smooth ER [Ramirez and Couve, 
2011]. At the ultrastructural level, the neuronal ER consists of complex 
cisternae, flattened sheets, and tubules which resemble that of other 
eukaryotic cells. The neuronal ER extends from the soma to the entire 
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dendritic arbor, some dendritic spines, and axons. The major component 
of ER in the soma and proximal dendritic compartment is rough ER, 
while the ER distributed in distal dendrites and axons comprise mostly 
smooth ER [Verkhratsky and Peterson, 2002; Ramirez and Couve, 
2011]. Within the soma and the proximal dendritic region, portions of ER 
come into close contact with the plasma membrane to form subsurface 
cisternae which play an important role in regulating neuronal excitability. 
The axonal ER network extend into the synapse where it is often closely 
associated with mitochondria [Berridge et al., 1998]. 
The ER contributes to multiple functions, including the synthesis of lipid 
and sterol, the regulation of intracellular Ca2+ dynamics, and the 
synthesis and post-translational modification of secretory and membrane 
proteins [Ramirez and Couve, 2011]. In the presynaptic compartment, 
ER regulates Ca2+-mediated processes involved in synaptic 
transmission. In response to membrane depolarization, Ca2+ enters 
presynaptic terminals through VGCC and NMDA receptors [McGuinness 
et al., 2010; Kunz et al., 2013], which in turn may trigger CICR. 
Additionally, Ca2+ may also be released through IP3R in response to 
activation of metabotropic receptors. Increased Ca2+ concentration near 
release sites triggers fusion of glutamate-containing synaptic vesicles 
with the plasma membrane, leading to release of glutamate into the 
synaptic cleft [Bardo et al., 2006; Mattson, 2010]. In the postsynaptic 
compartment, ER Ca2+ initiates gene transcription [Mellstrom and 
Naranjo, 2001], modulates membrane excitability, and synaptic plasticity 
[Stutzmann and Mattson, 2011]. Furthermore, the release of Ca2+ from 
ER has been proposed as a modulator of dendritic spine structure 
[Korkotian and Segal, 1998]. 
The ER is a highly versatile protein factory that is equipped with 
chaperones and enzymes essential for proper protein folding. Only 
successfully folded proteins are exported from the ER, while unfolded or 
misfolded proteins are retained and selectively degraded [Kleizen and 
Braakman, 2004]. Key chaperones and folding sensors in the ER 
include: glucose regulated protein 78 (GRP78; also known as 
Immunoglobulin Binding protein-BiP) and 94 (GRP94), lectin, calnexin, 
calreticulin, protein disulfide isomerase (PDI), and ERp57 [Brown and 
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Naidoo, 2012]. Perturbation of ER Ca2+ homeostasis lead to the 
accumulation of unfold proteins that trigger ER stores response or unfold 
protein response (UPR) [Berridge, 2002]. ER stress and activation of the 
UPR has been implicated in abnormal protein processing, which 
subsequently plays a role in the pathogenesis of AD [Salminen et al., 
2009; Katayama et al., 2004]. 
 
 
Introduction 
 
 
8 
 
Figure 1. Schematic representation of the main Ca2+ homeostatic 
machinery components in pre-and postsynaptic compartments of 
neurons. Schematic representation of the key component of Ca2+ 
homeostatic mechanisms discussed in the text. Arrows indicate direction of 
ion flux. ER, endoplasmic reticulum; RyR, ryanodine receptor; IP3R, inositol 
trisphosphate receptor; IP3, inositol 1,4,5-trisphosphate; PIP2, 
phosphatidylinositol 4,5-bisphosphate; SERCA, sarcoplasmic / endoplasmic 
Ca2+-ATPase; NMDA, N-methyl-D-aspartate; AMPA, -amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid; VGCC, voltage-gated Ca2+ channels; PLC, 
phospholipase C; SOCE, store-operated Ca2+ entry; NCX, Na+/Ca2+ 
exchanger; PMCA, plasma membrane Ca2+- ATPase. 
 
1.4 Ca2+ dysregulation in AD 
In 1989, Khachaturian proposed that sustained changes in Ca2+ 
homeostasis could provide the common pathway for aging and 
neuropathological changes associated with AD. This hypothesis was 
termed the calcium hypothesis of brain aging and AD [Khachaturian, 
1989]. Emerging evidence suggests that altered intracellular Ca2+ levels 
and/or disturbances in Ca2+ homeostasis affect cellular mechanisms 
underlying AD pathology. Previous studies have reported that the 
aggregation and formation of toxic A oligomers disrupt Ca2+ 
homeostasis. It has been reported that A oligomers can incorporate 
into the membrane and form ion-channel-like structures with high cation 
conductivity in the planar bilayer membrane [Arispe et al., 1993; Pollard 
et al., 1993; Quist et al., 2005] and the plasma membrane of Xenopus 
laevis oocytes [Demuro et al., 2011]. The presence of in situ A pores 
has also been observed in the neuronal cell membrane derived from AD 
patients [Inoue, 2008]. In addition to the pore formation mechanism, A 
oligomers have been shown to directly activate various Ca2+- permeable 
channels. Studies in rat cultured neurons have reported that A 
oligomers induce overactivation of NMDA and AMPA receptors, which in 
turn trigger mitochondrial dysfunction and neuronal apoptotic death 
[Alberdi et al., 2010]. A peptides also enhance Ca2+ influx through 
VGCC in human neuroblastoma cells and mouse cortical neurons 
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[Ekinci et al., 1999]. Furthermore, A oligomers can increase Ca2+ 
release from the ER stores via IP3 and RyR receptors in cultured 
neurons [Ferreiro et al., 2004]. An A peptide-mediated upregulation of 
RyR-3 expression has been described in neuronal cultures isolated from 
transgenic mice harboring the APPswe mutation [Supnet et al., 2006, 
2010]. Another mechanism by which A disrupts neuronal Ca2+ 
homeostasis is A-mediated production of reactive oxygen species, 
which may induce membrane lipid peroxidation. This results in the 
formation the aldehyde 4-hydroxynonenal which impairs the function of 
membrane transporters and ion channels leading to an elevation of 
[Ca2+]i [Hensley et al., 1994; Keller et al., 1998; Hermes et al., 2010]. 
In addition to their impact on the function of -secretase, PS mutations 
were reported to have a significant impact on Ca2+ signaling in various 
AD models. Studies in Xenopus laevis oocytes expressing PS1-M146V, 
PS2-N141I, and PS2-M239V mutation have illustrated an increased in 
IP3- mediated Ca2+ release from internal stores [Leissring et al., 1999a; 
1999b]. Similar results have been observed in brain slices from knock-in 
(KI) mice expressing PS1- M146V mutation and from 3xTg- AD mice 
harboring APPswe, Tau-P301L, and PS1-M146V mutation [Stutzmann et 
al., 2003; 2004; 2006]. A biological interaction of IP3R with FAD mutant 
PS1 and PS2 have been observed in the insect Sf9 cell lines. Single-
channel recordings of IP3R have shown that the Sf9 cells expressing 
either different PS1 mutations or PS2-N141I mutation enhance IP3R 
open probability and shift the channel gating toward a high open 
probability burst mode [Cheung et al., 2008; 2010]. Additionally, it has 
been reported that an alteration of PLC activity may be involved in FAD-
linked PS mutation. The increase in basal PLC activity has been 
detected in the human neuroblastoma transfected PS1 exon 9 deletion 
(PS1deltaE9) and PS1-M146V mutation [Cedazo-Minguez et al., 2002; 
Popescu et al., 2004]. A PS1 mutation –mediated dysfunction of RyRs 
have also being described in several models. Studies in cultured 
neurons isolated from PS1-M146V KI mice have illustrated up-regulated 
RyR expression levels [Chan et al., 2000] and increased RyR-evoked 
Ca2+ release [Smith et al., 2005]. Studies in brain slices derived from 
PS1-M146V KI mice and 3xTg- AD mice have demonstrated increased 
RyR-evoked Ca2+ responses across neuronal compartments, including 
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the soma and perinuclear regions with particularly high Ca2+ release in 
dendrites and spine heads [Stutzmann et al., 2006; Goussakov et al., 
2010]. In presymptomatic young 3xTg- AD mice, increased RyR-evoked 
Ca2+ responses are associated with an increase in RyR2 isoform 
expression [Chakroborty et al., 2009]. Consistent with these findings, the 
levels of RyR2 mRNA are also increased in the brain tissue samples 
from AD patients with mild cognitive impairment [Bruno et al., 2012]. 
Recent in vitro studies have provided evidence for a colocalization and 
physical interaction between PS and SERCA pump [Green et al., 2008; 
Jin et al., 2010]. Depletion of PS1 and PS2 results in diminished SERCA 
function, while the cells expressing PS1-M146V increase SERCA 
activity, suggesting that PS is necessary for proper functioning of 
SERCA [Green et al., 2008]. Furthermore, several studies have 
addressed the impact of PS mutations on the function of SOCE. A 
profound impairment of SOCE has been observed in fibroblasts isolated 
from PS1-M146V KI mice [Leissring et al., 2000], cell lines expressing 
PS1-M146L and PS2-N141I mutation, and primary cortical neurons 
derived from PS2-N141I transgenic mice [Yoo et al., 2000]. Additionally, 
studies using human B lymphocytes isolated from FAD patients with 
PS1 mutation have indicated an attenuated SOCE function and reduced 
STIM2 expression [Bojarski et al., 2009]. Furthermore, a downregulation 
of STIM2 protein has been reported in hippocampal cultures of PS1-
M146V KI mice [Sun et al., 2014]. Moreover, recent findings have shown 
that wild type PS can form low-conductance divalent-cation-permeable 
ion channels in the ER membrane and function as passive ER Ca2+ 
leakage channels. The balance between SERCA Ca2+ pump activity and 
PS-mediated passive Ca2+ leak channel determines the steady-state 
resting ER Ca2+ levels [Tu et al., 2006]. Studies based on fibroblast cell 
lines have demonstrated that fibroblasts bearing PS1 mutations, 
including M146V, L166P, A246E, E273A, G384A, and P436Q lack an 
ER Ca2+  leak function, leading to ER Ca2+ overload and increased Ca2+ 
release from the ER [Tu et al., 2006; Nelson et al., 2007, 2010]. Similar 
results have also been observed in cultured hippocampal neurons from 
3xTg AD mice [Zhang et al., 2010].  
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1.5 Synaptic dysfunction in AD 
Synaptic dysfunction and synapse loss contribute to the memory 
impairment and cognitive deficits in AD pathogenesis [Sheng et al., 
2012]. Several studies have examined the impact of A oligomers on 
synaptic function. Studies in organotypic hippocampal slices derived 
from APPswe mice demonstrated that A oligomers selectively depress 
glutamatergic synaptic transmission [Kamenetz et al., 2003]. In double 
knock in mice carrying APPswe and PS1-P264L mutation, an 
electrophysiological study reported a reduction in AMPA receptor 
function in acute hippocampal slices [Chang et al., 2006]. Consistent 
with this finding, a reduced expression of AMPA receptor subunit GluR1 
is observed in neuronal culture derived from APPswe mice treated with 
A oligomers [Ameida et al., 2005]. The application of A in cultured 
cortical neurons promotes endocytosis of NMDA receptors. Additionally, 
naturally secreted A reduces the surface NR1 subunit of NMDA 
receptors in cultured cortical neurons derived from APPswe mice [Synder 
et al., 2005]. Microinjection of A oligomers in rat brain has been shown 
to inhibit hippocampal long-term potentiation (LTP) [Walsh et al., 2002] 
and disrupt cognitive function [Cleary et al., 2005]. An impairment of 
LTP and an enhancement of long-term depression (LTD) have been 
reported in mouse hippocampal slices treated with A oligomers 
[Shanker et al., 2008]. Furthermore, it was found that the impairment of 
LTP occurs concomitantly with the appearance of intraneuronal A 
accumulation in hippocampal CA1 neurons in 3xTg-AD mice [Oddo et 
al., 2003].   
Recent investigations indicate the implication of dysregulated ER Ca2+ 
signaling in synaptic dysfunction. Electrophysiological studies in brain 
slices isolated from presymptomatic 3xTg AD mice have shown an 
exaggerated RyR-mediated CICR in dendritic processes and spine 
heads of prefrontal cortical pyramidal neurons [Goussakov et al., 2010]. 
Furthermore, RyR-mediated alterations in hippocampal synaptic 
plasticity and synaptic strength have been observed in the same mouse 
strain [Chakroborty et al., 2009]. These authors proposed that enhanced 
synaptic CICR may result in an abnormal synaptic transmission and 
contribute to cognitive deficits in AD. Additional evidence suggests a 
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contribution of FAD-linked PS mutations to cognitive dysfunction and the 
impairment of synaptic plasticity which can occur in the absence of 
amyloid and tau pathologies. Studies in PS1-M146V KI mice have 
demonstrated an impairment of hippocampus-dependent associative 
learning as measured by a contextual fear conditioning [Wang et al., 
2004]. Moreover, an impairment of hippocampal spatial memory has 
been reported in PS1-M146V KI mice [Sun et al., 2005] and PS1-L435F 
heterozygous KI mice [Xia et al., 2015]. A deterioration of muscarinic 
modulation of LTP [Wang et al., 2009] and an impairment of the long 
lasting form of LTP [Auffret et al., 2010] have been described in 
hippocampal slices of PS1-M146V KI mice. Additionally, an adverse 
effect of mutant PS1 on short term plasticity and LTP at hippocampal 
CA1 and CA3 synapses has been reported in PS1-L435F heterozygous 
KI mice [Xia et al., 2015]. 
 
1.6 Aberrant neuronal network hyperactivity in AD 
A growing number of studies in humans and mouse models of AD 
indicate that a perturbation of neuronal network activity contributes to 
AD pathogenesis. Aberrant excitatory network activity is observed in the 
brains of AD patients and may contribute to the disruption of cognitive 
function. It has been reported that the familial forms of AD are often 
associated with convulsive behavior [Palop and Mucke, 2009; Palop and 
Mucke, 2010; Dickerson et al., 2005; Sperling et al., 2010; Scharfman, 
2012]. The incidence of seizures is increased in patients with mild-to-
moderate AD. Additionally, severe AD cases are more likely to develop 
unprovoked seizure [Amatniek et al., 2006]. Studies in transgenic AD 
mice have also provided a possible connection between network 
hyperactivity and pathogenesis of seizures. Results from in vivo 
electroencephalographic (EEG) recordings in APPswe/ind mice have 
elucidated a pronounced epileptiform activity in cortical and 
hippocampal network. APPswe/ind mice also exhibit increased seizure 
acitivity induced by inhibition of GABAA receptors [Palop et al., 2007]. In 
APPswe/PS1deltaE9 mice, electrophysiological recordings have shown 
increased excitability in cortical pyramidal neurons. Additionally, a high 
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probability of epileptic seizures has been observed in young 
APPswe/PS1deltaE9 mice at an age when the first amyloid plaques begin 
to develop in the brain [Minkeviceine et al., 2009]. Recently, an in vivo 
two-photon Ca2+ imaging study has demonstrated an impairment of 
neuronal networks in double transgenic mice bearing mutant APPswe 
and PS1-G384A mutation (APP23/PS45 mice). Measuring spontaneous 
Ca2+ transients of layer 2/3 cortical neurons in vivo, the authors have 
shown that in the vicinity of amyloid plaques only half of the neurons 
were active in the normal frequency range. The remaining neurons were 
either silent or hyperactive. The authors further demonstrated that these 
hyperactive neurons were found in close proximity to the plaque border, 
while the proportion of silent cells gradually increased at greater 
distances from the amyloid plaques [Busche et al., 2008]. Additionally, a 
deterioration of visual cortical circuit function has been reported in 
APP23/PS45 mice [Grienberger et al., 2012]. Interestingly, an 
impairment of orientation and a direction tuning property was specific to 
hyperactive neurons which were located in the vicinity of amyloid 
plaques. Furthermore, a study in CA1 region of hippocampus has shown 
that an increase of neuronal hyperactivity can be observed prior to 
plaque deposition in 1-2-month-old APP23/PS45 mice. An early 
occurrence of hyperactivity is causally related to the action of soluble A 
oligomers [Busche et al., 2012]. 
Besides A-induced network hyperexcitability, recent studies have 
reported the evidence of epileptic seizures in AD patients with various 
PS1 mutations. Early epileptic seizures have been observed in patients 
with the L166P and E120G mutation, while the H163R and L282R 
mutations have been linked to a late onset of seizures [Moehlmann et 
al., 2002; Gomez-Tortosa et al., 2010]. Additionally, the following 
mutations have been related to the epileptic seizures in AD patients: 
E120D, M139I, M139V, M146V, H163R, S169L, G209V, A246E, 
M233T, A260V, and E280A [Mann et al., 2001; Velez-Pardo et al., 
2004]. Furthermore, it has been reported that also PS2 mutations might 
be related to epileptic seizures. The epileptic phenotype-associated with 
the PS2-N141I mutation has been reported in approximately 30% of 64 
AD patients [Jayadev et al., 2010]. Supporting these findings, studies in 
transgenic mice harboring PS1-A246E and PS2-N141L mutation 
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exhibited a reduced seizure threshold in response to kainic acid 
[Schneider et al., 2001]. Collectively, these evidence raise the possibility 
that PS mutation may contribute to the aberrant network 
hyperexcitability, however, the precise mechanisms underlying this 
phenomenon still remain unknown. 
 
1.7 Aim of this project 
The current project aims to understand the role of intracellular Ca2+ 
stores for in vivo AD-mediated neuronal network dysfunction by 
1. characterizing the ongoing neuronal activity in aged AD 
and WT mice by monitoring the relative proportion of silent, 
normal, and hyperactive neurons 
 
2. deciphering functional properties of the intracellular Ca2+ 
stores in amyloid-depositing mice as well as their 
contribution to dysregulation of intracellular Ca2+ 
homeostasis 
 
3. investigating the contribution of AD-linked PS1 mutation to 
the aberrant neuronal network activity 
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All experimental procedures were conducted according to German 
federal and state regulations and were approved by the state 
government of Baden-Württemberg. The experiments were performed in 
anesthetized animals. 
 
2.1 Animals 
Ten- to fourteen-month-old transgenic PS45 (heterozygous, PS45tg/-; 
homozygous, PS45tg/tg), APP23xPS45 (AD), and age-matched non-
transgenic (WT) mice of both sexes were used in this thesis. 
Additionally, 6-7-month-old PS45tg/- mice were used in some 
experiments. All transgenic lines express their transgenes under the 
control of Thy-1 promoter. The PS45 mice overexpress human G384A-
mutated PS1. The AD mice overexpress both mutant APP with the 
Swedish (670/671) mutation and the human G384A-mutated PS1. In 
these double transgenic mice, amyloid plaque deposition in the upper 
cortical layers starts at approximately 2-3 months of age and the density 
of plaques is highest in the frontal and somatosensory cortex. Cognitive 
deficits in spatial learning and memory in the Morris water maze task are 
observed at 6 months of age [Busche et al., 2008]. Animals were 
housed on a 12 hours light/dark cycle with food and water available ad 
libitum. 
 
2.2 Surgical Procedure 
Acute cranial window 
Mice were anesthetized using isoflurane (1-1.5% in O2; CP-Pharma, 
Germany) and kept on a warming plate (37C) to maintain body 
temperature. After injection of a local anesthetic (2% lidocaine; 20 mg 
lidocaine in 1 ml standard external saline), the skin located above the 
brain region of interest was removed to expose the skull. A custom-
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made recording chamber with an opening in the middle (Figure 2) was 
then glued to the skull with cyanoacrylic glue (UHU, Buhl-Baden, 
Germany). The skull was thinned under a dissecting microscope using 
dental drills. The mouse was transferred to the recording set-up, placed 
onto a warming plate and continuously supplied with 0.8-1% isoflurane 
in pure oxygen during the experiment. The body temperature was 
maintained at 36-37C and respiratory rate was continuously monitored 
and maintained at 80-120 bpm. The eyes were coated with Bepanthen 
(Bayer, Germany) to prevent dehydration. The recording chamber was 
perfused with warm (36-37C) extracellular perfusion saline containing 
(in mM): 125 NaCl, 4.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 
MgCl2, 20 glucose, pH 7.4, when bubbled with 95% O2 and 5% CO2. 
The position of the frontal cortex was located according to brain atlas 
coordinations: 3 to 3.5 mm anterior-posterior to Bregma (AP), 0.5 to 1.5 
mm medio-lateral to midline (ML) [Busche et al., 2008]. A small ( 1mm) 
craniotomy was performed above an area devoid of big blood vessels 
using a thin (30G) syringe needle. In all cases, after removing the bone 
flap the dura mater was left intact [Garaschuk et al., 2006]. 
 
 
 
Figure 2. A custom-made recording chamber. Left panel: Photograph of custom-
made recording chamber (top view) (modified from Garaschuk et al., 2006). Right 
panel: Schematics illustrating the recording chamber mounted on the skull. 
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2.3 In vivo two-photon imaging 
2.3.1 Set up 
In vivo imaging was performed with a custom-built two-photon 
microscope using a mode-locked Ti-Sapphire laser with a wavelength of 
710-990 nm (MaiTai, Spectra Physics, Mountain View, CA) and a laser 
scanning system (Olympus Fluoview, Olympus, Tokyo, Japan). An 
upright microscope (BX51WI, Olympus, Tokyo, Japan) and a water-
immersion objective (Nikon 40x, 0.8 NA, Tokyo, Japan) was attached to 
a laser scanning unit. 
 
2.3.2 In vivo visualization of neurons 
Multi-cell bolus loading technique 
The cortical neurons in layer 2/3 of the frontal cortex were stained in vivo 
with a Ca2+ sensitive dye Oregon Green 488 BAPTA-1 AM (OGB-1 AM, 
Molecular Probes, Eugene, USA) using multi-cell bolus loading 
technique (MCBL) as previously described [Garaschuk et al., 2006]. 
Briefly, the fluorescent calcium indicator dye was dissolved in dimethyl 
sulfoxide (DMSO) plus 20% Pluronic F-127 to yield a dye concentration 
of 10 mM and this solution was further diluted for a final concentration of 
0.5 mM with a standard pipette solution of the following composition (in 
mM): 150 NaCl, 2.5 KCl, 10 Hepes, pH 7.4. The dye solution was loaded 
in a micropipette (tip diameter 1 µm) and was pressure-ejected (2 min, 
60 kPa) into the cortex  200 m below the pia. After an hour the dye 
was fully taken up by neurons and astrocytes. Previous studies have 
reported that astrocytes tend to accumulate higher concentration of 
indicator dyes, thus the brightly loaded cells were likely to be non-
neuronal [Stosiek et al., 2003; Hirase et al., 2004; Garaschuk et al., 
2006]. During the experiments astrocytes were discriminated by their 
bright appearance and their cell-type-specific morphology. As shown 
previously [Garaschuk, 2013], amyloid plaques also bind OGB-1, 
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therefore this labeling protocol enables visualization of the plaques 
during an experiment.  
Two photon calcium imaging of neurons 
The somata of OGB-1 labeled neurons were imaged using an excitation 
wavelength of 800 nm. A 40x water-immersion objective and a zoom of 
x4 was used throughout the recording sessions. Spontaneous somatic 
Ca2+ transients were collected at the frame rate of 7 Hz. for a 6-min-long 
recording period. All images shown are maximum intensity projection of 
 3 µm, taken with a 1 µm step size. 
 
2.3.3 In vivo visualization of dendrites 
Shadow electroporation 
To investigate spontaneous Ca2+ transients in dendritic branches, the 
single-cell electroporation technique was performed as described 
previously [Nevian and Helmchen, 2007]. In brief, the individual 
pyramidal neurons in layer 2/3 of the frontal cortex were electroporated 
using glass pipettes with a tip diameter of < 1 µm filled with 2.5 mM 
Oregon Green BAPTA-1 hexapotassium salt (Life technologies, USA) 
dissolved in an intracellular solution containing (in mM): 175 K-
gluconate, 17.5 KCl, 5 NaCl, and 12.5 HEPES. After insertion of the 
pipette, brief pressure pulses were applied to eject small amounts of the 
dye and to produce a local stain of the extracellular space. This 
extracellular stain caused cell bodies to appear as negatively stained 
objects enabling targeting of the cell membrane with the pipette. As 
soon as the pipette touched the cell membrane, a negative current of 
500 nA was applied for 20-25 ms using a MVSC-02C iontophoresis 
system (NPI Electronic, Germany). After delivering the electroporation 
pulse, the soma and dendritic processes were rapidly loaded with dye. 
The pipette was then retracted slowly out of the brain. In these 
experiments, the pyramidal neurons were selected on the basis of their 
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morphological features which consist of (i) a pyramid-shaped soma, (ii) 
an apical dendrite extending towards the pial surface and a basal skirt, 
and (iii) an appearance of dendritic spines [Elston et al.,1996; Spruston, 
2008] (Figure 3). 
 
Figure 3. In vivo shadow electroporation. (A) Side view of the experimental 
arrangement. Note the position of the dye-containing (OGB-1 hexapotassium salt) 
electroporation pipette, water immersion objective, perfusion system, and the recording 
chamber glued on the skull. Layer 1 and 2/3 of the frontal cortex are indicated as L1 
and L2/3, respectively. The arrows indicate the flow direction of the extracellular saline 
perfusing the cortical surface. (B) Maximum intensity projection (160-180 µm below the 
dura, step 0.5 µm) of a two-photon image stack of an electroporated pyramidal neuron 
in layer 2/3 of the frontal cortex in a PS45tg/- mouse. 
 
Two photon calcium imaging of dendrites 
Spontaneous Ca2+ transients in dendritic branches were recorded at 
least 30 minutes after electroporation to allow recovery of the cells and 
equilibration of the dye in the dendritic processes. Due to the technical 
limitations, the recordings of spontaneous Ca2+ transients in dendrites 
and their corresponding somata were taken separately for each field of 
view. Using an excitation wavelength of 800 nm, we first monitored the 
spontaneous Ca2+ transients in somata of electroporated neurons 
followed by the imaging of dendritic branches. A 40x water-immersion 
objective and a zoom of x4 was used throughout the recording sessions. 
Single and paired apical dendritic branches of normal and hyperactive 
cells were chosen for this study. Dendritic Ca2+ imaging was performed 
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at a frame rate of 8 Hz. for a 6-min-long recording period. Unless 
otherwise indicated, all images shown are maximum intensity 
projections of  2 µm, taken with a 0.5 µm step size. To determine the 
location of the dendritic branches of interest, a reference image was 
taken and compared to the images in the image stack of the soma and 
entire dendritic tree taken at the end of the recording. In these 
experiments, the apical dendrites were chosen according to the 
following criteria: (i) non-overlapping dendritic branches, and (ii) 
dendritic length within the plane of focus of more than 30-40 µm. 
 
2.3.4 In vivo visualization of axonal boutons 
Virus injection  
Previous studies have reported that layer 2/3 pyramidal neurons receive 
some ascending interlaminar excitatory input from layer 5/6 pyramidal 
neurons [Thomson and Bannister, 2003; Shepherd et al., 2005]. To 
investigate spontaneous Ca2+ transients in ascending axons of layer 5/6 
cortical neurons, we combined the viral labeling technique with the acute 
cranial window preparation. The viral transfection by adeno-associated 
virus (AAV) was used to deliver the genetically encoded Ca2+ indicator 
GCaMP6f (rAAV-synapsin(syn)-GCaMP6f, serotype 1, University of 
Pennsylvania Gene Therapy Program Vector Core) into the cortical 
neurons. Mice were anesthetized with a combination of medetomidine 
(0.5 mg/kg BW, Alfavet Tierarzneimittel GmbH, Neumünster, Germany), 
midazolam (5 mg/kg BW, Hameln Pharma plus GmbH, Hameln, 
Germany), and fentanyl (0.05 mg/kg BW, Albrecht GmbH, Aulendorf, 
Germany) injected intraperitoneally (IP) and transferred to a stereotaxic 
apparatus. Under a dissecting microscope, a high-speed drill was used 
to make a small hole (0.5 x 0.5 mm) through the skull. We first 
attempted to label the cortical neuron in layer 5/6 of the frontal cortex, 
however, due to the space restriction it was difficult to cut an acute 
cranial window after viral injection. Therefore the nearby motor cortex 
was chosen for these experiments. The viral solution was injected slowly 
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(< 0.5 µl in 5 min) through the hole at a depth of 700-800 µm below the 
pia. The pipette penetration angle was set 45- 50 from the horizontal 
plain to minimize the cortical tissue damage overlying the labeled 
neurons. The skin incision was then closed with sutures. A non-steroidal 
anti-inflammatory drug carprofen (5 mg/kg BW, Pfizer GmbH, Berlin, 
Germany), and the combination 3 antidotes atipamezole (2.5 mg/kg BW, 
Alfavet Tierarzneimittel GmbH, Neumünster, Germany), flumazenil (0.5 
mg/kg BW, Fresenius Kabi Deutschland GmbH, Bad Homburg, 
Germany), and naloxone (1.2 mg/kg BW, Hameln Pharma plus GmbH, 
Hameln, Germany) were injected subcutaneously immediately after the 
surgery. 
 
Two photon calcium imaging of axonal boutons 
Preparation of acute cranial window and in vivo two-photon imaging 
were performed 14 days after virus injection. A small craniotomy was 
performed 0.5 – 0.7mm anterior to the injection area with the intact dura 
mater. Due to the limitations of our two-photon imaging setup, which 
allowed us only to visualize cortical layer 1-3, the recording of 
spontaneous somatic Ca2+ transients in layer 5/6 neurons was not 
included in this study. Axonal branches were selected on the basis of 
imaging characteristics, including high signal-to-noise ratio and lack of 
overlapping axons. Axonal boutons were identified as bright spots along 
the axon backbone [Shepherd et al., 2002; Stettler et al., 2006; De 
Paola et al., 2006]. Excitation wavelength of 920 nm was used to 
visualize GCaMP6f-labeled axonal boutons. A 40x water-immersion 
objective and a zoom of x4 to x5 was used throughout the recording 
sessions. The spontaneous Ca2+ transients in axonal boutons were 
collected similar to dendritic recording. All images shown are maximum 
intensity projection of  2 µm, taken with a 0.5 µm step size. 
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2.4 Immunohistochemistry 
After in vivo experiments the brains were removed and fixed with 4% 
formaldehyde in phosphate buffer saline (PBS) for 24 hours at 4C. The 
brains were then cryoprotected in 25% sucrose in PBS for 24 hours at 
4C. After cryoprotection, the brains were embedded in embedding 
medium (Tissue Tek, SAKURA, USA). Embedded tissues were stored 
at -80C until further use. An anti-ionized calcium binding adaptor 
molecular 1(Iba1) antibody (Wako, VA, USA) was used to visualize 
microglial morphology. An anti-CD68 antibody (Abd Serotec, 
Oxfordshire, UK) was used to elucidate phagocytic activity of microglia. 
An anti- glial fibrillary acidic protein (GFAP) antibody (Dako, USA) was 
used to visualize astrocytes and astrogliosis. Thioflavin-S (Sigma, USA) 
was used to stain amyloid plaques. 
The staining procedure was performed on free-floating sagittal 
cryoslices (thickness 50 µm) at room temperature. The sections were 
incubated in a blocking solution containing 5% normal donkey serum 
(Jackson Immuno Research/Dianova) and 1% Triton-X 100 (Sigma, 
USA) in PBS for 1 hour to prevent non-specific background staining. 
After blocking the sections were incubated with the primary antibodies 
diluted in the blocking solution. The primary antibodies were used in the 
following concentration: anti-Iba1 (1:500), anti-CD68 (1:1000), and anti-
GFAP (1:500). After incubation, the sections were rinsed in PBS three 
times for 10 minutes and incubated with AF 594- and AF 488-
conjugated secondary antibodies (1:1000 in PBS+2% bovine serum 
albumin; Invitrogen) for 2 hours in the dark. Afterwards, the sections 
were washed three times in PBS for 10 minutes. Amyloid plaques were 
stained with Thioflavin-S (1x10-6% in PBS) for 8 minutes and then 
washed three times in PBS for 10 minutes. Finally, the sections were 
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transferred to Superfrost Plus charged glass slides (Langenbrink, 
Emmendingen, Germany) and mounted in Vectashield Mounting 
Medium (Vector Laboratories, USA). 
Fluorescence-stained sections were examined with a two-photon 
microscope. Images were acquired with a 40x water-immersion 
objective (Nikon 40x, 0.8 NA, Tokyo, Japan) and a zoom of x2.5. 
Fluorophores were excited with 800 nm. Emission wavelengths for Iba1 
and Thioflavin-S were separated from each other with a 515 nm dichroic 
mirror. Emission wavelengths for GFAP and Thioflavin-S were 
separated from each other with a 570 nm dichroic mirror. All images 
shown are maximum intensity projection of  3 µm, taken with a 1 µm 
step size. 
 
2.5 Drug application 
NMDA (10 mM, Sigma-Aldrich, USA), caffeine (80 mM, Sigma-Aldrich, 
USA), cyclopiazonic acid (CPA, 400 µM, Sigma-Aldrich, USA) and MK-
801 hydrogen maleate (200 µM, Sigma-Aldrich, USA) were used in 
these experiments. NMDA was dissolved in a solution containing (in 
mM): 150 NaCl, 2.5 KCl, 10 Hepes. Caffeine was dissolved in a solution 
containing (in mM): 120 NaCl, 4.5 KCl, 1.25 NaH2PO4, 10 HEPES, 1 
MgCl2, and 2 CaCl2. NMDA and caffeine were locally applied to neurons 
using a pressure-application system. For improved visualization of the 
area subjected to the drug application and precise positioning of the 
pipette, the cell-impermeable fluorescent dye Alexa Fluor 594 (AF 594, 
50 µM, Invitrogen, USA) was routinely added to the drug-containing 
solution. The application pipette (tip diameter 1 µm) was placed 30-40 
µm away from the neurons of interest. NMDA and caffeine were applied 
using a pressure pulse of 50-55 kPa (10-15 ms for NMDA and 40-50 ms 
for caffeine). CPA and MK-801 were added to the extracellular saline 
perfusing the recording chamber attached to the mouse’s skull (‘bath’ 
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application). CPA was applied 30 minutes prior to recording the effect of 
the drug. MK-801 was applied for a long period of time and the 
recording was performed every 10 minutes for the duration of 2 hours. 
 
2.6 Data analysis 
The image analyses were performed off-line with Image J 
(http://rsb.info.nih.gov/ij/) and custom-made routines of the Igor Pro 
software (Wavemetrics, Lake Oswego, Oregon, United States). If not 
indicated otherwise, data were expressed as median  interquartile 
range (IQR). 
 
2.6.1 Analysis of spontaneous Ca2+ transients of somata, dendrites, 
and axonal boutons 
To calculate the Ca2+-dependent increase in fluorescence, regions of 
interest (ROIs) were drawn around individual neuronal somata, dendritic 
branches, and axonal boutons. After background subtraction, the values 
were expressed as relative change in fluorescence (F/F). For each 
ROI, a transient was accepted as a signal, when its peak amplitude was 
greater than three times the standard deviation of the baseline noise.  
Analysis of spontaneous somatic Ca2+ transients 
The following parameters of Ca2+ transients were analyzed: i) frequency, 
ii) amplitude, iii) T-half (duration of Ca2+ transients at half peak 
amplitude), and iv) decay time constant (tau). All recorded neurons were 
classified based on the frequency of their spontaneous Ca2+ transients 
as silent (0-0.25 transients/min), normal (0.26-4 transients/min), and 
hyperactive (>4 transients/min) similar to previous study [Busche et al., 
2008]. The amplitudes were calculated as the difference between the 
peak of fluorescence and the mean baseline fluorescence immediately 
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before the peak. Tau values were obtained by fitting the decay of Ca2+ 
transients with an exponential function from 90% to 10% of the 
maximum amplitude (Figure 4). 
 
 
Figure 4. Representative example of spontaneous somatic Ca2+ transients recorded 
from an OGB-1 labeled neuron. Arrows indicate parameters analyzed in this study 
(amplitude, T-half, and tau). 
 
Analysis of spontaneous dendritic Ca2+ transients 
The frequency and the amplitude of spontaneous dendritic Ca2+ 
transients were analyzed similar to somatic data. Additionally, the 
spontaneous Ca2+ transients obtained from paired dendritic branches 
recording were classified into two groups: local and synchronous 
transients. The local transients invaded individual dendritic branches 
independently, while transients occurring simultaneously in both 
dendritic branches were termed synchronous. 
 
Analysis of spontaneous Ca2+ transients of axonal boutons 
We monitored the frequency and amplitude of spontaneous Ca2+ 
transients in individual axonal boutons. Furthermore, these 
transients were classified based on the number of spikes. All 
transients with a single peak and an immediate return to baseline 
Material and Methods 
 
 
27 
 
were considered as single transients whereas as series of 
transients showing two or more spikes without returning to 
baseline was considered as bursts. 
 
2.6.2 Analysis of agonist-induced Ca2+ transients 
We analyzed the following parameters: amplitude, T-half, tau, area 
under the curve (AUC) of AF 594 signals, and AUC ratio. The amplitude, 
T-half, and tau of agonist-induced Ca2+ transients were measured 
similar to those of spontaneous Ca2+ transients. The AUC of AF 594 
signals is proportional to the amount of agonist applied.  The AUC ratio 
was calculated by normalizing the AUC of agonist-induced Ca2+ 
transients to the AUC of AF 594 signals observed for the same cell. This 
value represents the response of a neuron per unitary stimulus (here: 
agonist application). 
 
2.7 Statistical analysis 
Statistical analyses were performed using the software on the 
VassarStats Statistical Computation Web Site (http://vassarstats.net/). 
Comparisons between two independent data sets were conducted with 
Mann-Whitney Test. Wilcoxon Signed-Rank Test was used for multiple 
measurements within the same data set. Chi-square test was used for 
comparing the fractions of silent, normal, and hyperactive cells between 
different data sets. Kolmogorov-Smirnov test was used for comparing 
the cumulative distribution of data. P<0.05 was considered as 
statistically significant. 
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3.1   Aging and ongoing amyloid deposition potentiate 
neuronal hyperactivity 
A recent study in a mouse model of AD (APPswe/PS1G384A) at 6-10 
months of age demonstrated an in vivo impairment of neuronal network 
function [Busche et al., 2008]. Using 2-photon Ca2+ imaging, the authors 
measured the frequency of spontaneous Ca2+ transients in individual 
layer 2/3 neurons and observed an AD-mediated increase in the 
proportion of either silent or hyperactive cells in the half of neuronal 
population, while the remaining half of cortical neurons showed normal 
activity. Hyperactive cells were found in close proximity of amyloid 
plaques, whereas silent and normal cells were found throughout the 
cortex. These data provided the first in vivo evidence for a disturbed 
Ca2+ homeostasis in mouse models of AD, but the mechanisms 
underlying this disturbance as well as their relation to the function of the 
intracellular Ca2+ stores remained unknown. We conducted similar 
experiment in 10-14-month-old AD and WT mice to find out if the aging 
process per se affects network activity (Figure 5A). As abundant amyloid 
plaques were observed throughout the cortical area in AD mice of this 
age, only clusters of neurons in the close vicinity of amyloid plaques (10-
20 µm) were analyzed. All recorded neurons were classified based on 
the frequency of spontaneous Ca2+ transients as silent, normal, and 
hyperactive cells according to the frequency boundaries established in 
the previous study [Busche et al., 2008]. Interestingly, we observed a 
robust increase in the fraction of hyperactive cells in WT and AD mice 
compared to 6-10-month-old animals analyzed previously (23.50% 
versus 1.2% for WT and 38.1% versus 21% for AD, **p<0.0001; Chi-
Square test; compare our Figure 5B to Figure 1 in Busche et al.,2008). 
When comparing the fraction of silent, normal, and hyperactive cells 
between AD (n= 260 in 10 mice) and WT mice (n=226 cells in 9 mice) of 
the same age (Figure 5C), we found a significant increase in the fraction 
of hyperactive cells (38.3411.48% in AD versus 21.747.78% in WT, 
**p=0.003; Mann-Whitney test) and a substantial decrease in the 
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fraction of normal cells (44.748.03% in AD versus 65.226.73% in WT, 
**p= 0.002; Mann-Whitney test) in AD relative to WT mice. The fraction 
of silent cells, however, was similar in both strains (15.705.84% in AD 
versus 12.506.49% in WT, p= 0.15; Mann-Whitney test). Furthermore, 
we analyzed the frequency distribution of spontaneous Ca2+ transients 
using cumulative probability histograms. The frequency distribution in 
AD mice was significantly shifted to the right, implicating a higher 
frequency of spontaneous Ca2+ transients than in WT mice (**p=0.006; 
Kolmogorov-Smirnov test) (Figure 5D). 
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Figure 5. Altered spontaneous neuronal activity in aged amyloid-depositing 
mice. (A) Maximum intensity projection (167-173 µm (WT) and 172-178 µm (AD) 
below the dura, step 1 µm) of layer 2/3 neurons of the frontal cortex in a WT and an AD 
mouse. Plaques are shown in yellow. The right panel shows spontaneous Ca2+ 
transients recorded simultaneously from neurons marked with respective numbers in 
the left panel. Traces are color-coded to mark neurons according to their frequency: 
green for normal (0.26-4 transients/min), red for hyperactive (>4 transients/min), and 
blue for silent cells (0-0.25 transients/min). (B) Histograms showing the frequency 
distribution of spontaneous Ca2+ transients in 10-14-month-old WT (n = 226 cells in 9 
mice) and AD mice (n = 260 cells in 10 mice). Insets: pie charts showing the relative 
proportion of silent, normal, and hyperactive cells. The proportion of the three cell 
types is significantly different between the two mouse strains (**p= 0.0002, Chi-square 
test). (C) Box-and-whisker plots illustrating the median fraction of three cell types in 
WT and AD mice (n= 9 mice and 10 mice, respectively). There is a significant increase 
in the fraction of hyperactive cells (**p=0.003; Mann-Whitney test) and a substantial 
decrease in the fraction of normal cells (**p= 0.002; Mann-Whitney test) in AD 
compared to WT mice. The fraction of silent cells is similar between the two mouse 
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strains (p= 0.15; Mann-Whitney test). ns= not significant. (D) The cumulative 
probability histograms showing a significantly higher frequency of spontaneous Ca2+ 
transients in AD relative to  WT mice (**p= 0.006, Kolmogorov-Smirnov test). 
 
In summary, these data indicate the presence of an aging-related 
increase in neuronal hyperactivity which is observed not only in AD but 
also in WT mice. Additionally, the amyloid deposition in AD mice further 
potentiates neuronal hyperactivity. These findings suggest that both 
aging and AD impair network Ca2+ homeostasis thus supporting 
Khachaturian’s hypothesis that aging- and AD-related neuronal 
impairments may share similar mechanisms. 
 
3.2   In vivo properties of somatic intracellular Ca2+ stores in 
WT and AD mice 
3.2.1   Enhanced caffeine-induced Ca2+ release from intracellular  
stores in amyloid-depositing mice 
Previous in vitro Ca2+ imaging studies indicated that RyR-mediated Ca2+ 
release is enhanced in cortical and hippocampal neurons from 3xTg AD 
mice and PS1-M146V KI mice [Smith et al., 2005; Stutzmann et al., 
2006; Chakroborty et al., 2009; Chan et al., 2000]. This finding provided 
in vitro evidence that dysregulation of intracellular Ca2+ stores is 
implicated in AD pathology. However, the in vivo properties of the 
intracellular Ca2+ stores and their contribution to dysregulation of 
intracellular Ca2+ homeostasis in the intact AD brain remained unclear. 
To address this issue, we have established a technique enabling us to 
study the in vivo properties of RyRs in layer 2/3 cortical neurons. Initially 
we applied 80 mM caffeine (50-55 kPa for 40-50 ms) to the cells of 
interest by pressure application. No caffeine-induced Ca2+ transients 
were observed, probably due to a low concentration of caffeine reaching 
the RyRs in our application paradigm. As it was not possible to increase 
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the caffeine concentration in the application pipette because of solubility 
issues and the duration of the application due to the movement artifacts, 
we supported the caffeine-induced Ca2+ release by increasing the 
content of Ca2+ within the intracellular Ca2+ stores [Garaschuk et al., 
1997]. Local application of glutamate receptor agonist NMDA was used 
to increase the Ca2+ content within the stores in all subsequent 
experiments. We first pressure-applied 10 mM NMDA (50-55 kPa for 10-
15 ms) followed by 80 mM caffeine (50-55 kPa for 40-50 ms) using the 
‘double pipette technique’ (Figure 6A and B). AF 594 (50 µM) was 
routinely added to the drug-containing solutions to visualize the 
application pipettes and the size of the drug affected area. 
Cyclopiazonic acid (CPA) is a known reversible inhibitor of the SERCA 
pump. Because of the presence of Ca2+ leak channels in the ER 
membrane [Garaschuk et al., 1997], blockade of the pump results in the 
depletion of intracellular Ca2+ stores. To confirm that CPA effectively 
depleted intracellular Ca2+ stores in our in vivo conditions, the effects of 
CPA on caffeine-induced Ca2+ transients was examined in AD mice. 400 
µM CPA was added to the extracellular solution superfusing the surface 
of the dura (so-called “bath application”, Garaschuk et al., 2006) for 30 
minutes and then NMDA and caffeine were applied again as described 
above. The caffeine-induced Ca2+ transients were abolished in the 
presence of CPA (Figure 6C, middle panel) and recovered upon wash-
out of CPA (Figure 6C, right panel), demonstrating that bath-applied 
CPA (400 µM, 30 minutes) successfully blocks Ca2+ release from the 
intracellular Ca2+ stores in vivo. 
For comparison of agonist-induced Ca2+ transients between WT and AD 
mice we used the following parameters: amplitude, T-half, tau, and AUC 
ratio (Figure 6D). We first assessed the amount of NMDA and caffeine 
released in this protocol by calculating the AUC of AF 594 signals. As 
shown in Figure 7 and Table 1, the AUC of AF 594 signals of NMDA and 
caffeine application were similar in WT (n= 63 cells in 5 mice) and AD 
mice (n= 51 cells in 5 mice) (p= 0.26 and p = 0.10, respectively; Mann-
Whitney test), indicating that these agonists were applied in equal 
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amounts in both strains. Hence, this experimental protocol provided 
reliable data and enabled us to compare the results obtained in both 
strains. 
 
 
 
Figure 6. In vivo Ca2+ release from neuronal intracellular Ca2+ stores. (A) A 
schematic drawing illustrating the double pipette technique. (B) Maximum intensity 
projection (155-161 µm below the dura, step 1 µm) of layer 2/3 neurons of the frontal 
cortex in an AD mouse. Two pipettes containing either 10 mM NMDA or 80 mM 
caffeine are positioned close to cells of interest. The drugs are pressure-applied (50-55 
kPa, 10-15 ms for NMDA and 50-55 kPa, 40-50 ms for Caffeine) to evoke respective 
Ca2+ transients. (C) NMDA- and caffeine-induced Ca2+ transients recorded 
simultaneously from neurons marked with respective numbers in (B) before, during, 
and after application of a SERCA pump inhibitor CPA (400 µM). Note that the caffeine-
induced Ca2+ transients are abolished in the presence of CPA. Triangles indicate the 
time points of NMDA and caffeine applications. (D) Representative example of a 
caffeine-induced Ca2+ transient. Arrows indicate parameters analyzed in this study 
(amplitude, T-half, tau, and AUC). 
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Figure 7. Similar amounts of NMDA and caffeine are applied in WT and AD mice. 
The distributions of median AUC of AF 594 signals of NMDA-AF 594 solution (A) and 
caffeine-AF 594 solution (B) in WT and AD mice (n= 5 mice per group). The AUC of AF 
594 signals for both solutions are similar between WT and AD mice (p = 0.26 and p = 
0.10, respectively; Mann-Whitney test). ns = not significant. 
 
We further compared caffeine-induced Ca2+ transients between WT and 
AD mice. As illustrated in Figure 8 and Table 1, the T-half, tau, and AUC 
ratio of caffeine-induced Ca2+ transients were significantly larger in AD 
compared to WT mice (*p= 0.04, *p= 0.04, and *p= 0.01, respectively; 
Mann-Whitney test). The amplitudes of caffeine-induced Ca2+ transients, 
however, were similar in the two mouse strains (p= 0.14; Mann-Whitney 
test). These results indicate that Ca2+ release from caffeine-sensitive 
stores is increased in AD compared to WT mice. Next, we compared the 
NMDA-induced Ca2+ transients between the two mouse strains. We 
found that the amplitudes, T-half, tau, and AUC ratio of NMDA-induced 
Ca2+ transients were similar in WT and AD mice (p=0.37, p=0.41, 
p=0.41, and p=0.33, respectively; Mann-Whitney test) (Figure 9A-D and 
Table 2). 
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Figure 8. Caffeine-induced Ca2+ release from intracellular Ca2+ stores is stronger 
in AD compared to WT mice. Box-and-whisker plots illustrating the distribution of 
median amplitude (A), T-half (B), tau (C), and AUC ratio (D) of caffeine-induced Ca2+ 
transients in WT and AD mice (n= 5 mice per group). The T-half, tau, and AUC ratio in 
AD are significantly increased compared to WT mice (*p= 0.04, *p= 0.04, and *p= 0.01 
respectively; Mann-Whitney test). However, the amplitudes are similar in both strains 
(p = 0.14; Mann-Whitney test). AUC = area under the curve; ns = not significant.   
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Table 1. Summary of the amplitude, T-half, tau, AUC of AF 594 signals, and AUC ratio 
of caffeine-induced Ca2+ transients in WT and AD mice. Data are presented as median 
 IQR. 
 
 
* Significantly different compared to the respective values in WT mice (p=0.04 for T- 
half and tau, p=0.01 for AUC ratio; Mann-Whitney test). 
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Figure 9. Similarity of NMDA-induced Ca2+ transients in WT and AD mice. Box-
and-whisker plots illustrating the distribution of median amplitude (A), T-half (B), tau 
(C), and AUC ratio (D) of NMDA-induced Ca2+ transients in WT and AD mice (n =5 
mice per group). There are no significant differences between WT and AD mice in 
amplitude, T-half, tau, and AUC ratio of NMDA-induced Ca2+ transients (p=0.37, 
p=0.41, p=0.41, and p=0.33, respectively; Mann-Whitney test). AUC = area under the 
curve; ns = not significant. 
 
Table 2. Summary of the amplitude, T-half, tau, AUC of AF 594 signals, and AUC ratio 
of NMDA-induced Ca2+ transients in WT and AD mice. Data are presented as median  
IQR. 
 
There are no significant differences in all parameters between WT and AD mice. 
(p>0.05 for all cases; Mann-Whitney test).  
 
To investigate differences in the Ca2+ release from caffeine-sensitive 
stores of silent, normal, and hyperactive cells in AD mice, we compared 
all parameters of caffeine-induced Ca2+ transients (amplitude, T-half, 
Tau, and AUC ratio) among different cell types. Interestingly, we 
observed a significant increase in the T-half and tau of caffeine-induced 
Ca2+ transients in hyperactive cells (n= 17 cells in 5 mice) compared to 
that measured in silent (n= 13 cells in 5 mice) and normal cells (n= 21 
cells in 5 mice,**p<0.01; Mann-Whitney test). Although there was a 
trend toward increased AUC ratios in hyperactive cells, it did not reach 
the level of statistical significance (p>0.05; Mann-Whitney test) (Figure 
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10A-D and Table 3). The amplitudes, however, were similar across the 
three cell types (p>0.05; Mann-Whitney test). All values measured in 
silent cells were indistinguishable from that measured in normal cells 
(p>0.05; Mann-Whitney test).  
 
 
Figure 10. Larger Ca2+ release from caffeine-sensitive stores of hyperactive cells 
in AD mice. Box-and-whisker plots illustrating the distribution of amplitude (A), T-half 
(B), tau (C), and AUC ratio (D) of caffeine-induced Ca2+ transients of silent (n= 13 cells 
in 5 mice), normal (n = 21 cells in 5 mice), and hyperactive cells (n= 17 cells in 5 mice) 
in AD mice. The T-half and tau of hyperactive cells are significantly increased 
compared to silent and normal cells (**p<0.01 for all cases; Mann-Whitney test). There 
is a trend toward increased AUC ratio in hyperactive cells compared to silent and 
normal cells, but this does not reach the level of statistical significance (p>0.05 for all 
cases; Mann-Whitney test). The amplitudes, however, are similar across the three cell 
types (p>0.05 for all cases; Mann-Whitney test). All values measured in silent cells are 
not significantly different from that measured in normal cells (p>0.05 for all cases; 
Mann-Whitney test). ns= not significant. 
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Table 3. Summary of the amplitude, T-half, tau, and AUC ratio of caffeine-induced 
Ca2+ transients of silent, normal, and hyperactive cells in AD mice. Data are presented 
as median  IQR. 
 
**  Significantly different compared to the respective values measured in silent and 
normal cells (p<0.001 for all cases; Mann-Whitney test).   
 
In summary, here we have established a robust protocol for functional 
analyses of somatic intracellular Ca2+ stores in vivo. In the intact 
cerebral cortex of AD mice we observed prolonged RyR-mediated Ca2+ 
release signals consistent with the overfilling of the intracellular Ca2+ 
stores and/or altered function of RyRs. When compared to silent and 
normal cells, the largest effects were observed in hyperactive cells. 
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3.2.2   NMDA receptors activation-mediated Ca2+ release  from 
internal stores in amyloid-depositing mice 
To find out whether the activation of NMDA receptors is able to induce 
CICR from the intracellular Ca2+ stores in vivo in amyloid-depositing 
mice, we analyzed NMDA-induced Ca2+ transients recorded under 
control conditions, during the application of CPA, and after washout of 
CPA (Figure 11A-B). To ensure that the obtained results are not biased 
by unequal agonist applications, we compared the AUC of AF 594 
signals. We found that these values were similar across the three 
conditions (18.734.57 F/F*s for control, 20.100.84 F/F*s for CPA, 
and 22.242.98 F/F*s for wash-out of CPA, p>0.05; Wilcoxon Signed-
Rank test) (Figure 11C), indicating that NMDA was applied in equal 
amounts in all three conditions. 
For comparison we normalized the amplitudes, T-half, tau, and AUC 
ratio of NMDA-induced Ca2+ transients during CPA treatment to their 
respective control values. As illustrated in Figure 11D and Table 4, CPA 
significantly reduced the amplitudes of NMDA-induced Ca2+ transients in 
hyperactive cells (n= 21 cells in 5 mice,*p<0.05; Wilcoxon Singed-Rank 
test), but not in silent and normal cells (silent, n= 6 cells and normal, n= 
36 cells in 5 mice, p>0.05 for; Wilcoxon Signed-Rank test). Additionally, 
a trend toward reduction in T-half was observed in the three cell types, 
but it did not reach a level of statistical significance (p>0.05; Wilcoxon 
Signed-Rank test). The tau and AUC ratio, however, were not affected 
by CPA (p>0.05; Wilcoxon Signed-Rank test). Together, these results 
indicate that NMDA-induced Ca2+ transients are potentiated by CICR 
selectively in hyperactive cells, likely due to a stronger overfilling of their 
intracellular Ca2+ stores. 
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Figure 11. NMDA receptor-mediated activation of CICR in amyloid-depositing 
mice. (A) Maximum intensity projection (169-175 µm below the dura, step 1 µm) of 
layer 2/3 neurons of the frontal cortex in an AD mouse. A pipette containing 10 mM 
NMDA and 50 µM AF 594 is positioned close to cells of interest. The drug is pressure-
applied (50-55 kPa for 10-15 ms) to evoke Ca2+ transients before, during, and after 
bath application of CPA. Plaques are shown in yellow. (B) Representative traces 
showing NMDA-induced Ca2+ transients measured in a hyperactive cell marked with a 
white asterisk in (A). The triangles indicate the time points of the NMDA application. 
Note a reduction in the amplitude of NMDA-induced Ca2+ transient in the presence of 
CPA. (C) Box-and-whisker plots illustrating the distributions of median AUC of AF 594 
signals in control, CPA, and wash-out conditions (p>0.05; Wilcoxon Signed-Rank test, 
n= 5 mice). (D) The distribution of median normalized amplitude, T-half, tau, and AUC 
ratio of NMDA-induced Ca2+ transients measured in silent, normal, and hyperactive 
cells (n= 5 mice). In the presence of CPA, there is a significant decrease in the 
amplitude of hyperactive cells (*p<0.05; Wilcoxon Signed-Rank test), but not of silent 
and normal cells (p>0.05; Wilcoxon Signed-Rank test). A trend toward reduction in the 
T-half is observed in three cell types, but this trend does not reach the level of 
statistical significance (p>0.05; Wilcoxon Signed-Rank test). The tau and AUC ratio of 
three cell types are not affected by CPA (p>0.05; Wilcoxon Signed-Rank test). All 
values measured under CPA are normalized to their respective control values. A 
dashed help line is drawn at 100%. ns = not significant. 
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Table 4. Summary of the normalized amplitude, T-half, tau, and AUC ratio of NMDA-
induced Ca2+ transients in AD mice. Data are presented as median  IQR. 
 
 
* Significantly different compared to the control condition (100%) (p<0.05;  Wilcoxon 
Signed-Rank test) 
 
 
3.3   Neural network response to the empty intracellular Ca2+ 
stores 
Besides the general notion that Ca2+ disturbances are involved in the 
pathogenesis of AD, very little is known about the role of the intracellular 
Ca2+ stores for dysregulation of in vivo neuronal network activity in AD 
mice. Our next aim was to elucidate the relevance of intracellular Ca2+ 
stores to the ongoing spontaneous Ca2+ transients in both pre- and 
postsynaptic compartments. 
3.3.1   The effect of SERCA blocker CPA on spontaneous somatic 
Ca2+ transients in WT and AD mice 
To investigate the contribution of Ca2+ release from intracellular Ca2+ 
stores to spontaneous neuronal activity, the effect of CPA on 
spontaneous Ca2+ transients was examined in 10-14-month-old WT and 
AD mice. As already noted above, bath-applied CPA reversibly inhibits 
Ca2+ uptake into the ER via inhibition of SERCA pumps and leads to 
store depletion. Therefore, spontaneous Ca2+ transients of OGB-1 
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labeled cortical neurons were measured before, during, and after bath 
application of CPA (Figure 12A-B). Following 30 min bath application of 
CPA, there was a dramatic decrease in the fraction of hyperactive cells 
and also a proportional increase in the fraction of normal cells in AD 
mice (*p<0.05; Wilcoxon Signed-Rank test). This effect was reversible 
upon wash-out of CPA (p>0.05 when compared to control conditions; 
Wilcoxon Signed-Rank test). The fraction of silent cells was not affected 
by CPA (p>0.05; Wilcoxon Signed-Rank test). In WT mice, however, the 
fractions of three cell types under CPA were similar across the three 
conditions (p>0.05; Wilcoxon Signed-Rank test) (Figure 13A-D and 
Table 5). 
 
 
Figure 12. Effect of SERCA blocker CPA on spontaneous Ca2+ transients of 
cortical neurons in WT and AD mice. A and C, Maximum intensity projection (157-
162 µm (WT) and 161-166 µm (AD) below the dura, step 1 µm) of layer 2/3 neurons of 
the frontal cortex in a WT and an AD mouse. Plaques are shown in yellow. B and D, 
Traces show spontaneous Ca2+ transients recorded before, during, and after bath 
application of CPA from neurons marked with respective numbers (A and C) in a WT 
and an AD mouse. The colored dots indicate the type of neuron (blue, silent; green, 
normal; and red, hyperactive). Note a remarkable decrease in the frequency of 
spontaneous Ca2+ transients in the presence of CPA selectively in AD mice. 
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Figure 13. Store depletion normalizes pathological activity patterns in amyloid 
depositing mice. (A and B) Histograms showing the frequency distributions of 
spontaneous Ca2+ transients recorded before, during, and after bath application of 
CPA in WT (n = 121 cells in 5 mice) and AD (n = 135 cells in 5 mice) mice. Insets: pie 
charts showing the relative proportion of silent, normal, and hyperactive cells under 
respective condition (C and D) Box-and-whisker plots illustrating the median fraction of 
the three cell types under three conditions in WT and AD mice (n= 5 mice per group). 
There is a significant decrease in the fraction of hyperactive cells (*p<0.05; Wilcoxon 
Signed-Rank test) and a substantial increase in the fraction of normal cells (*p<0.05; 
Wilcoxon Signed-Rank test) in the presence of CPA in AD mice, whereas the fraction 
of silent cells is similar across the three conditions (p>0.05; Wilcoxon Signed-Rank 
test). In WT mice CPA does not affect the fraction of three cell types (p>0.05; Wilcoxon 
Signed-Rank test). 
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Table 5. Summary of the fractions of silent, normal, and hyperactive cells under 
control, CPA, and wash-out condition in WT and AD mice. Data are presented as 
median  IQR. 
 
 
*  Significantly different compared to their respective control and wash-out values  
(p<0.05; Wilcoxon  Signed-Rank test).   
 
We further normalized all values (frequency, amplitude, T-half, and tau) 
under CPA to their respective control values for comparison of the two 
conditions. There was a pronounced decrease in the frequency of both 
normal and hyperactive cells in AD mice (*p<0.05; Wilcoxon Signed-
Rank test). Moreover, the amplitudes were significantly smaller in 
hyperactive cells (*p<0.05; Wilcoxon Signed-Rank test) but not in normal 
cells (p>0.05; Wilcoxon Signed-Rank test). There were no significant 
changes in neither T-half nor tau of normal and hyperactive cells 
(p>0.05; Wilcoxon Signed-Rank test). In WT mice, however, no 
significant changes in the frequency, amplitudes, T-half, and tau values 
were observed after depletion of Ca2+ stores with CPA (p>0.05 for all 
cases; Wilcoxon Signed-Rank test) (Figure 14 and Table 6). Collectively, 
these data indicate that intracellular Ca2+ stores influence the frequency 
of spontaneous activity in AD but not in WT mice. Furthermore, blocking 
the Ca2+ release from intracellular stores normalizes the aberrant 
network activity in AD mice by reducing neuronal hyperactivity. 
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Figure 14. Intracellular Ca2+ stores are selectively involved in controlling the 
ongoing neuronal activity in AD mice. A comparison of median normalized 
frequency, amplitude, T-half, and tau of spontaneous Ca2+ transients of normal and 
hyperactive neurons in WT (left panel) and AD mice (right panel) (n= 5 mice per 
group). CPA significantly decreases the frequency of spontaneous Ca2+ transients of 
both normal and hyperactive cells in AD mice (*p<0.05, Wilcoxon Signed-Rank test). 
The amplitudes of hyperactive cells (*p<0.05; Wilcoxon Signed-Rank test), but not that 
of normal cells (p>0.05; Wilcoxon Signed-Rank test) are smaller in the presence of 
CPA. T-half and tau of both cell types are not affected by CPA (p>0.05; Wilcoxon 
Signed-Rank test). CPA does not influence neither normal nor hyperactive cells in WT 
mice (p>0.05; Wilcoxon Signed-Rank test). All values measured under CPA are 
normalized to their respective control values.  Dashed help lines are drawn at 100%. 
 
Table 6. Summary of the normalized frequency, amplitude, T-half, and tau of normal 
and hyperactive cells in WT and AD mice. Data are presented as median  IQR. 
 
 
* Significantly different compared to their respective normalized control values (100%) 
(p<0.05; Wilcoxon Signed-Rank test). 
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3.3.2 The role of G384A PS mutation for neuronal hyperactivity 
Our data described above revealed a significant contribution of the 
intracellular Ca2+ stores to the AD-mediated neuronal hyperactivity in the 
plaque vicinity. This hyperactivity might be due to a direct effect of 
amyloid species [Busche et al., 2008] or, alternatively, to other factors 
such as proinflammatory substances released from plaque-associated 
activated microglia and astrocytes [review in Brawek and Garaschuk, 
2014]. Another possible factor accounting for this phenomenon could be 
an AD-associated PS mutation. To understand the mechanisms 
underlying CPA-sensitive neuronal hyperactivity in AD mice, we 
repeated the experiments described above in age-matched PS45tg/- and 
PS45tg/tg mice, which harbor the same PS mutation as APP23xPS45 
mice. 
 
3.3.2.1    Neuronal hyperactivity occurs independently of plaque 
formation and inflammation in PS45 mice 
To test whether PS45 mice develop amyloid plaques and/or exhibit any 
signs of inflammation, we analyzed tissue samples of PS45tg/tg mice by 
means of immunocytochemistry. Tissue samples of WT and AD mice 
were used as a negative and a positive control, respectively. 
As illustrated in Figure 15A-L, Iba-1 positive microglial cells in PS45tg/tg 
mice exhibited a typical ramified morphology defined by long thin 
processes and small somata, similar to microglia cells in WT mice. The 
CD68 (a marker of phagocytosis, predominantly localizes to lysosomes 
and endosomes) immunoreactivity of microglial cells in PS45tg/tg was 
comparable to that of WT mice. Additionally, Thioflavin-S positive 
amyloid plaques were observed only in AD, but not in PS45tg/tg and WT 
mice.  
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Figure 15. No evidence of microglial activation in PS45tg/tg mice. Sagittal brain 
sections of WT, PS45tg/tg, and AD mice at 10-14 months of age are processed for a 
triple immunofluorescence staining with Iba-1 antibody for microglia (green, A, E, I), 
CD68 for marker of activated microglia with phagocytic activity (red, B, F, J), and 
Thioflavin-S for amyloid plaques (blue, C, G, K). Merged images of the three mouse 
strains are shown in D, H, and L. The Iba-1 positive microglial cells in PS45tg/tg mice 
(E) exhibit a typical ramified morphology similar to those in WT mice (A). CD68 
immunoreactivity in the PS45tg/tg (F) and WT mice (B) is less intense than in AD mice 
(J). Microglial cells in AD mice show a hyperthrophic/amoeboid morphology (I) and 
strong expression of CD68 immunoreactivity (J) in the areas surrounding amyloid 
plaques (L). In contrast to AD mice, there is no positive staining of amyloid plaques in 
the PS45tg/tg and WT mice. Data shown in this and the next figure were acquired by 
Rosa Maria Olmedillas. 
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In contrast, the CD68-positive microglial cells in AD mice had activated 
hypertrophic/amoeboid morphology, particularly in the areas 
surrounding amyloid plaques. Similar results were obtained in 15 
sections of 5 mice in each mouse strain. 
 
 
Figure 16. No apparent astrogliosis in PS45tg/tg mice. Sagittal brain sections of WT, 
PS45tg/tg, and AD mice at 10-14 months of age are stained with anti- GFAP antibody 
for visualization of astrocyte (red, A, D, G) and Thioflavin-S for visualizing amyloid 
plaques (blue, B, E, H). The merged images of the three mouse strains are shown in 
C, F, and I. The GFAP-positive astrocytes in PS45tg/tg have a morphology similar to 
that in WT mice. In AD mice, the reactive astrocytes are found in close proximity to 
amyloid plaques. Thioflavin-S positive dense-cored compact plaques are observed 
only in AD mice. 
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Next, we investigated the astroglial morphology and reactive astrogliosis 
using an antibody against GFAP, an intermediate filament protein which 
is expressed by astrocytes and is upregulated upon astrocyte activation. 
As shown in Figure 16A-I, GFAP-positive astrocytes in PS45tg/tg had 
morphology similar to that in WT mice. In AD mice, astrocytes with 
hypertrophy of proximal processes, a characteristic of reactive 
astrocytes, were apparent in close proximity to amyloid plaques.  
Together, these data indicate that PS45tg/tg mice do not develop amyloid 
plaque depositions. Additionally, there are no signs of microglial 
activation and reactive astrogliosis in PS45tg/tg mice, indicating that the 
histological features of inflammation are not observed in this mouse 
strain. Because of the even lower gene dosage in PS45tg/- mice, we 
assume that the results obtained above also apply to this mouse strain. 
 
3.3.2.2 Spontaneous network activity in PS45 mice 
We first characterized the general features of spontaneous Ca2+ 
transients in PS45tg/- and PS45tg/tg mice. As shown in Figure 17A-D and 
Table 7, the fraction of silent, normal and hyperactive cells in PS45tg/- 
(n= 139 cells in 5 mice) and PS45tg/tg mice (n= 141 cells in 5 mice) were 
indistinguishable from each other (p= 0.34, p=0.29, p=0.52, for silent, 
normal, and hyperactive cells, respectively; Mann-Whitney test). 
Additionally, the frequency distribution of spontaneous Ca2+ transients 
appeared similar in both strains (p=0.23; Kolmogorov-Smirnov test). 
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Figure 17. Characterization of spontaneous network activity in PS45tg/- and 
PS45tg/tg mice. Histograms showing the frequency distributions of spontaneous Ca2+ 
transients in 10-14-month-old PS45tg/- (n= 139 cells in 5 mice) (A) and PS45tg/tg (n = 
141 cells in 5 mice) (B) mice. Insets: pie charts showing the relative proportion of 
silent, normal, and hyperactive cells. (C) Box-and-whisker plots illustrating the median 
fraction of silent, normal, and hyperactive cells in PS45tg/- and PS45tg/tg mice (n= 5 
mice). The fraction of three cell types measured in PS45tg/- are indistinguishable from 
that measured in PS45tg/tg mice (p>0.05 for all cases; Mann-Whitney test). ns= not 
significant. (D) The cumulative probability histogram showing similar frequency 
distribution for spontaneous Ca2+ transients recorded in PS45tg/-  and PS45tg/tg mice (p= 
0.23, Kolmogorov-Smirnov test). 
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Table 7. Summary of the fractions of silent, normal, and hyperactive cells in PS45tg/- 
and PS45tg/tg mice. Data are presented as median  IQR. 
 
The fractions of three cell types are similar in both strains (p= 0.34, p= 0.29, and p= 
0.52 for silent, normal, and hyperactive cells, respectively; Mann-Whitney test). 
 
Next, we analyzed amplitudes, T-half, and tau of spontaneous Ca2+ 
transients in normal and hyperactive cells. For clarity, we compared 
these parameters in two ways: first –comparison between the two 
different cell types (normal and hyperactive cells). Second – comparison 
between the two different mouse strains (PS45tg/- and PS45tg/tg). We 
found that the values measured in normal and hyperactive cells were 
not significantly different across either cell types or mouse strains 
(p>0.05 for all cases; Mann-Whitney test) (Figure 18 and Table 8). Thus, 
all parameters measured in PS45tg/- mice were similar to those obtained 
in PS45tg/tg mice, indicating that the frequency and the general features 
of spontaneous Ca2+ transients in both strains are independent of 
mutant PS1 gene dosage. 
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Figure 18. General features of spontaneous Ca2+ transients in PS45tg/- and 
PS45tg/tg mice. A comparison of median amplitude (A), T-half (B), and tau (C) of 
spontaneous Ca2+ transients of normal and hyperactive cells in PS45tg/- and PS45tg/tg 
mice (n= 5 mice per group) under control conditions. There is no significant difference 
across either cell types or mouse strains (p>0.05; Mann-Whitney test). ns = not 
significant. 
 
 
Table 8. Summary of the amplitude, T-half, and tau of spontaneous Ca2+ transients of 
normal and hyperactive cells in PS45tg/- and PS45tg/tg mice. Data are presented as 
median  IQR. 
 
 
There are no significant differences in all values measured in normal and hyperactive 
cells across either cell types or mouse strains (p>0.05 for all cases; Mann-Whitney 
test). 
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3.3.2.3   Characteristics of spontaneous Ca2+ transients in WT, 
PS45tg/-, PS45tg/tg, and AD mice 
To study if the AD-associated PS mutation per se has an effect on 
network activity, we further compared the fractions of the three cell types 
in PS45tg/- and PS45tg/tg mice to our previous results obtained under 
control conditions in WT and AD mice. Surprisingly, the fractions of 
hyperactive cells in both PS45 strains were similar to AD mice (p=0.11 
for PS45tg/- and p=0.06 for PS45tg/tg mice; Mann-Whitney test) and these 
fractions were significantly larger compared to WT mice (*p=0.03 for 
PS45tg/-, *p=0.01 for PS45tg/tg and AD mice; Mann-Whitney test). The 
fractions of normal cells in both PS45 strains were similar to WT mice 
(p=0.29 for PS45tg/- and p= 0.09 for PS45tg/tg mice; Mann-Whitney test) 
and these fractions tended to be larger relative to AD mice (*p=0.04 for 
PS45tg/- and *p= 0.03 for PS45tg/tg mice; Mann-Whitney test). The 
fractions of silent cells were similar across the four strains (p>0.05 for all 
cases; Mann-Whitney test) (Table 9). Next, we compared the general 
features of spontaneous Ca2+ transients (amplitude, T-half, and tau) of 
normal and hyperactive cells among different mouse strains. As shown 
in Figure 19 A-C and Table 10, there were no significance differences in 
all values across either cell types or mouse strains (p>0.05 for all cases; 
Mann-Whitney test). 
 
Table 9. Summary of the fractions of silent, normal and hyperactive cells in WT, 
PS45tg/-, PS45tg/tg, and AD mice. Data are presented as median  IQR. 
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   *  Significantly different compared to the fraction of normal cells in AD mice (p=0.04 
for PS45tg/- , p=0.03 for PS45tg/tg, and p=0.02 for WT; Mann-Whitney test).   
 
  Significantly different compared to the fraction of hyperactive cells in WT mice 
(p=0.03 for PS45tg/-, p=0.01 for PS45tg/tg, and p=0.01 for AD; Mann-Whitney test). 
 
 
 
 
 
 
Figure 19. General features of spontaneous Ca2+ transients in WT, AD, PS45tg/-, 
and PS45tg/tg mice. A comparison of median amplitude (A), T-half (B), and tau (C) of 
spontaneous Ca2+ transients of normal and hyperactive cells in WT, PS45tg/- , PS45tg/tg, 
and AD mice (n= 5 mice per group) under control condition. There are no significant 
differences in all values measured in normal and hyperactive cells across either cell 
types or mouse strains (p>0.05 for all cases; Mann-Whitney test). ns = not significant. 
 
Table 10. Summary of the amplitude, T-half, and tau of spontaneous Ca2+ transients of 
normal and hyperactive cells in WT, PS45tg/-, PS45tg/tg, and AD mice under control 
condition. Data are presented as median  IQR. 
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There are no significant differences in all values measured in normal and hyperactive 
cells across either cell types or mouse strains (p>0.05 for all cases; Mann-Whitney 
test). 
 
Collectively, these data indicate that a significant increase in the fraction 
of hyperactive cells can be observed in both PS45 and AD mice, while a 
prominent reduction in the fraction of normal cells is seen in AD mice 
only. The fraction of silent cells, however, is similar across all mouse 
strains. Additionally, the general features of spontaneous Ca2+ transients 
are indistinguishable in all transgenic mice in this study. 
 
3.3.2.4   The contribution of intracellular Ca2+ stores to 
spontaneous neuronal activity in PS45 mice 
In the next step, we analyzed the effect of CPA on spontaneous 
neuronal activity in PS45 mice. Interestingly, the obtained results from 
either PS45tg/- or PS45tg/tg replicated our findings observed in AD mice 
(Figure 20A-B and 21A-B). Following 30 min bath application of CPA, 
there was a striking reduction in the fraction of hyperactive cells 
(*p<0.05; Wilcoxon Signed-Rank test) and a substantial increase in the 
fraction of normal cells (*p<0.05; Wilcoxon Signed-Rank test). The 
fractions of silent cells were unaffected by CPA in both strains (p>0.05; 
Wilcoxon Signed-Rank test) (Figure 21C-D and Table 11). 
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Figure 20. Effect of SERCA blocker CPA on spontaneous Ca2+ transients of 
cortical neurons in PS45tg/- and PS45tg/tg mice. A and C: Maximum intensity 
projection (158-164 µm (PS45tg/-) and 161-167 µm (PS45tg/tg) below the dura, step 1 
µm) of layer 2/3 neurons of the frontal cortex in a PS45tg/- and a PS45tg/tg mouse, 
respectively. B and D: Traces are spontaneous Ca2+ transients recorded before, 
during, and after bath application of CPA from neurons marked with respective 
numbers in A and C. The colored dots indicate the type of neuron (blue, silent; green, 
normal; and red, hyperactive). Note a remarkable decrease in the frequency of 
spontaneous Ca2+ transients in the presence of CPA in both strains. 
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Figure 21. Blocking the Ca2+ release from the intracellular stores reduces 
hyperactivity in PS45 mice. (A and B) Histograms showing the frequency 
distributions of spontaneous Ca2+ transients. Insets: pie charts showing the relative 
proportion of silent, normal, and hyperactive cells recorded before, during, and after 
bath application of CPA in PS45tg/- (n= 139 cells in 5 mice) and PS45tg/tg (n = 141 cells 
in 5 mice) mice. (C and D) Box-and-whisker plots illustrating the median fractions of 
the three cell types under the three conditions in PS45tg/- and PS45tg/tg mice (n= 5 mice 
per group). Note a significant decrease in the fraction of hyperactive cells (*p<0.05; 
Wilcoxon Signed-Rank test) and a proportional increase in the fraction of normal cells 
(p>0.05; Wilcoxon Signed-Rank test) in the presence of CPA in both mouse strains. 
The fraction of silent cells is similar across the three conditions (p>0.05; Wilcoxon 
Signed-Rank test). 
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Table 11.  Summary of the fractions of three cell types under control, CPA, and wash-
out condition in PS45tg/- and PS45tg/tg mice. Data are presented as median  IQR. 
 
 
*  Significantly different compared to their respective control and wash-out values 
(p<0.05; Wilcoxon  Signed-Rank test). 
 
 
 
Detailed analyses showed that the frequency of normal and hyperactive 
cells was significantly reduced by CPA in both mouse strains (*p<0.05; 
Wilcoxon Signed-Rank test). Likewise, CPA significantly decreased the 
amplitudes of hyperactive cells (*p<0.05; Wilcoxon Signed-Rank test) 
but not those of normal cells (p>0.05; Wilcoxon Signed-Rank test). 
However, T-half and tau of normal and hyperactive cells were not 
affected by CPA (p>0.05; Wilcoxon Signed-Rank test) (Figure 22 and 
Table 12). These findings are consistent with our results obtained in AD 
mice. 
 
 
Results 
 
 
61 
 
Figure 22. Intracellular Ca2+ stores are involved in controlling neuronal activity in 
PS45tg/- and PS45tg/tg mice. A comparison of median normalized frequency, 
amplitudes, T-half, and tau of spontaneous Ca2+ transients of normal and hyperactive 
cells in PS45tg/- (left panel) and PS45tg/tg (right panel) mice (n= 5 mice per group). CPA 
significantly decrease the frequency of both normal and hyperactive cells in PS45tg/- 
and PS45tg/tg mice (*p<0.05; Wilcoxon Signed-Rank test). The amplitudes of 
hyperactive cells (*p<0.05; Wilcoxon Signed-Rank test), but not that of normal cells 
(p>0.05; Wilcoxon Signed-Rank test), in both mouse strains are smaller in the 
presence of CPA. T-half and tau of normal and hyperactive cells in both mouse strains 
are not affected by CPA (p>0.05, Wilcoxon Signed-Rank test). All values measured 
under CPA are normalized to their respective control values. Dashed help lines are 
drawn at 100%. 
 
Table 12. Summary of the normalized frequency, amplitude, T-half, and tau in PS45tg/- 
and PS45tg/tg mice. Data are presented as median  IQR. 
 
 
* Significantly different compared to the normalized values under control condition 
(100%) (p<0.05; Wilcoxon Signed-Rank test). 
 
 
Thus, we concluded that intracellular Ca2+ stores influence the frequency 
of spontaneous activity in both PS45tg/- and PS45tg/tg mice, similar to the 
situation in AD mice. Furthermore, the store-mediated neuronal 
hyperactivity occurred in PS45 mice independently of plaque formation 
and inflammation suggesting that mutation in PS gene represents one of 
the mechanisms underlying neuronal hyperactivity. 
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3.3.2.5   Characteristics of spontaneous Ca2+ transients in young  
adult PS45 mice 
Our findings raised the question whether the PS mutation-mediated 
neuronal hyperactivity occurs in an age-dependent manner. To this end, 
we extended our investigation to young adult PS45 mice at 6-7 months 
of age. As the results obtained above in PS45tg/- and PS45tg/tg mice were 
similar, we performed the experiments in PS45tg/- mice only. To 
investigate the involvement of PS mutation in neuronal activity in young 
adult mice, we compared the fractions of the three cell types (silent, 
normal, hyperactive) between young adult PS45tg/- (n= 142 cells in 5 
mice) and age-matched WT mice analyzed previously (compared our 
Figure 23A to Figure 1 in Busche et al. 2008). Interestingly, the fraction 
of hyperactive cells in young adult PS45tg/- tended to be larger than 
those in WT mice (9.1% versus 1.2%). A significant difference in the 
proportion of the three cell types was observed between the mouse 
strains (**p<0.001, Chi-Square test). Thus, the PS mutation-mediated 
neuronal hyperactivity is already presented in young adult animals. 
We then compared the fraction of the cell types and the frequency 
distribution of spontaneous Ca2+ transients between young adult and 
aged PS45tg/- mice. As shown in Figure 23A-D and Table 13, there was 
a significant increase in the fraction of hyperactive cells and a 
substantial decrease in the fraction of normal cells in aged PS45tg/- 
compared to young adult mice of the same strain (*p= 0.01 for both 
cases; Mann-Whitney test). The fraction of silent cells, however, was 
similar in both age groups (p= 0.34, Mann-Whitney test). Furthermore, 
the population of imaged neurons in aged PS45tg/- mice showed a higher 
frequency than in young adult animals as demonstrated by a rightward 
shift in the cumulative probability histograms (**p<0.001, Kolmogorov-
Smirnov test). These results are consistent with our previous data 
observed in 10-14-month-old WT and AD mice suggesting that the aging 
process leads to an increase in neuronal hyperactivity. 
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Figure 23. Aging-mediated neuronal hyperactivity in PS45tg/- mice. (A and B) 
Histograms showing the frequency distributions of spontaneous Ca2+ transients in 6-7-
month-old (n= 142 cells in 5 mice) and 10-14-month-old PS45tg/- (n= 139 cells in 5 
mice, the same data set as the one shown in Figure 17A) mice. Insets: pie charts 
showing the relative proportion of silent, normal, and hyperactive cells. Note a 
remarkable increase in the fraction of hyperactive cells in aged PS45tg/- mice. (C and 
D) Box-and-whisker plots illustrating the median fraction of three cell types in young 
adult and aged PS45tg/- mice (n= 5 mice per group). There is a prominent increase in 
the fraction of hyperactive cells and a proportional decrease in the fraction of normal 
cells in 10-14-month-old PS45tg/- mice compared to young adult animals (*p=0.01 for 
both cases; Mann-Whitney test). The fraction of silent cells is similar in both age 
groups (p=0.34; Mann-Whitney test). Cumulative probability histograms showing a 
higher frequency of spontaneous Ca2+ transients in the neuronal population analyzed 
in aged PS45tg/- than in young adult mice of the same strain (**p< 0.001, Kolmogorov-
Smirnov test). ns= not significant. 
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Table 13.  Summary of the fractions of three cell types in young adult and aged          
PS45 tg/- mice. Data are presented as median  IQR. 
 
* Significantly different compared to the respective values in young adult PS45 tg/- mice 
(p=0.01 for both cases; Mann-Whitney test). 
 
 
Next, we analyzed the general features of spontaneous Ca2+ transients 
in young adult PS45tg/- mice. As illustrated in Figure 24A-C and Table 
14, both normal and hyperactive cells had similar amplitudes, T-half, and 
tau (p>0.05 for all cases, Mann-Whitney test). When comparing the two 
age groups, there was no significant difference in the amplitudes of 
normal and hyperactive cells (p>0.05 for all cases, Mann-Whitney test). 
Interestingly, both normal and hyperactive cells in aged animals 
exhibited a significantly prolonged T-half (*p= 0.01 for normal and *p= 
0.04 for hyperactive cells; Mann-Whitney test) and tau (*p= 0.02 for 
normal and *p= 0.03 for hyperactive cells; Mann-Whitney test) compared 
to the values obtained in young adult animals. Our findings indicate that 
aging also influences the general features of spontaneous neuronal 
activity in PS45 mice as suggested by prolonged T-half and tau of 
spontaneous Ca2+ transients. 
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Figure 24. Prolonged spontaneous Ca2+ transients in aged PS45tg/- mice. A 
comparison of amplitude (A), T-half (B), and tau (C) of spontaneous Ca2+ transients of 
normal and hyperactive cells in young adult and aged PS45tg/- mice under control 
conditions. In young adult PS45tg/- mice, there are no significant differences between 
normal and hyperactive cells for all parameters tested (p>0.05 for all cases, Mann-
Whitney test). When comparing between the two age groups, both normal and 
hyperactive cells of aged PS45tg/- mice exhibit significantly prolonged T-half (*p= 0.01 
for normal and *p= 0.04 for hyperactive cells; Mann- Whitney test) and tau (*p= 0.02 for 
normal and *p= 0.03 for hyperactive cells; Mann-Whitney test). The amplitudes of both 
cell types are similar in both age groups (p>0.05 for all cases, Mann-Whitney test). ns= 
not significant. 
 
Table 14. Summary of the amplitude, T-half, and tau of spontaneous Ca2+ transients of 
normal and hyperactive cells in young adult and aged PS45+/- mice. Data are 
presented as median  IQR. 
 
 
 
*  Significantly different compared to the values measured in normal cells of young 
adult mice (p=0.01 for T-half and p=0.02 for tau; Mann-Whitney test).  
 
  Significantly different compared to the values measured in hyperactive cell of 
young adult mice (p=0.04 for T- half and p=0.03 for tau; Mann-Whitney test). 
Results 
 
 
66 
 
3.3.2.6 Contribution of intracellular Ca2+ stores to spontaneous 
neuronal activity in young adult PS45 mice 
Next, we analyzed the effect of CPA on spontaneous neuronal activity in 
young adult PS45tg/- mice (Figure 25). Upon CPA-induced ER Ca2+ 
depletion, we observed a significant reduction in the fraction of 
hyperactive cells (*p<0.05, Wilcoxon Signed-Rank test) and a modest 
increase in the fraction of normal cells, but this did not reach statistical 
significance (p>0.05, Wilcoxon Signed-Rank test). The fraction of silent 
cells was not affected by CPA (p>0.05, Wilcoxon Signed-Rank test) 
(Figure 26A-B and Table 15). To characterize the effect of CPA in more 
detail, we normalized all values under CPA (frequency, amplitude, T-
half, and tau) to their respective control values. CPA significantly 
decreased the frequency of normal as well as hyperactive cells (*p<0.05 
for both cases; Wilcoxon Signed-Rank test). In the presence of CPA, 
amplitudes were significantly smaller in hyperactive cells (*p<0.05; 
Wilcoxon Signed-Rank test), but not in normal cells (p>0.05; Wilcoxon 
Signed-Rank test). T-half and tau of normal and hyperactive cells were 
unaltered by CPA (p>0.05; Wilcoxon Signed-Rank test) (Figure 26C and 
Table 16). 
 
 
Figure 25. Effect of SERCA blocker CPA on spontaneous Ca2+ transients of 
cortical neurons in young adult PS45tg/- mice. (A) Maximum intensity projection 
(163-169 µm below the dura, step 1 µm) of layer 2/3 neurons of the frontal cortex in a 
PS45tg/- mouse at the age of 6 months. (B) Traces are spontaneous Ca2+ transients 
recorded before, during, and after bath application of CPA from neurons marked with 
respective numbers in (A). The colored dots indicate the type of neuron (blue, silent; 
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green, normal; and red, hyperactive). Note a remarkable decrease in the frequency of 
spontaneous Ca2+ transients in the presence of CPA. 
 
 
 
Figure 26. Neuronal hyperactivity in young adult PS45tg/- mice is sensitive to 
SERCA pump blockade. (A) Histograms showing the frequency distributions of 
spontaneous Ca2+ transients recorded before, during, and after bath application of 
CPA in young adult PS45tg/- mice (n= 142 cells in 5 mice). Insets: pie charts showing 
relative proportions of silent, normal, and hyperactive cells and the three conditions (B) 
Box-and-whisker plots illustrating the median fraction of the three cell types (n= 5 
mice). Under CPA there is a small but significant decrease in the fraction of 
hyperactive cells (*p<0.05; Wilcoxon Signed-Rank test) and a slight increase in the 
fraction of normal cells, but this does not reach statistical significance (p>0.05; 
Wilcoxon Signed-Rank test). The fraction of silent cells is not affected by CPA (p>0.05; 
Wilcoxon Signed-Rank test). (C) The distribution of median normalized frequency, 
amplitude, T-half, and tau of spontaneous Ca2+ transients measured under CPA in 
normal and hyperactive cells (n= 5 mice). CPA significantly decreases the frequency of 
both normal and hyperactive cells (*p<0.05 for both cases, Wilcoxon Signed-Rank 
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test). Amplitudes of hyperactive cells are significantly smaller under CPA (*p<0.05; 
Wilcoxon Signed-Rank test), but not those of normal cells. T-half and tau of both cell 
types are unaltered by CPA (p>0.05 for both cases; Wilcoxon Signed-Rank test). All 
values measured under CPA are normalized to their respective control values. Dashed 
help lines are drawn at 100%. ns= not significant. 
 
 
Table 15. Summary of the fractions of silent, normal, and hyperactive cells before, 
during and after bath application of CPA in young adult PS45tg/- mice. Data are 
presented as median  IQR. 
 
 
 
* Significantly different compared to the respective control value (p<0.05; Wilcoxon 
Signed-Rank test). 
 
Table 16. Summary of the normalized frequency, amplitude, T-half, and tau of normal 
and hyperactive cells in young adult PS45tg/-mice. Data are presented as median  
IQR. 
 
 
 
*  Significantly different compared to their normalized values under control condition 
(100%) (p<0.05; Wilcoxon Signed-Rank test). 
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In summary, blocking Ca2+ release from intracellular stores reduced 
hyperactivity in young adult PS45tg/- mice and normalized the neuronal 
network activity. These findings are consistent with our results obtained 
in aged PS45tg/- mice, indicating that in PS45tg/- mice intracellular Ca2+ 
stores are involved in controlling the frequency of spontaneous Ca2+ 
transients in an age-independent manner. 
 
 
 
3.3.2.7  Presynaptic Ca2+ signals and the role of intracellular Ca2+ 
stores in PS45 mice  
Mounting evidence suggests that the presynaptic intracellular Ca2+ 
stores may participate in triggering neurotransmitter release [Llano et al., 
2000; Emptage et al., 2001; Bardo et al., 2002; Simkus and Stricker, 
2002]. To elucidate whether the store-mediated neuronal hyperactivity in 
PS45 mice is caused by presynaptic mechanisms, we labeled neurons 
in layer 5/6 of the motor cortex with AAV-GCaMP6f and analyzed their 
axonal projections to superficial cortical layer 1 (Figure 27A and B). The 
spontaneous Ca2+ transients in axonal boutons were monitored before, 
during, and after bath application of CPA (Figure 28A and B), and the 
frequencies as well as the amplitudes were analyzed across the three 
conditions. 
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Figure 27. Layer 5/6 cortical neurons in the motor cortex labeled with AAV-
GCaMP6f. (A) Schematics showing intracortical connections in the motor cortex. 
Labeled neurons in L5/6 are colored in green and unlabeled neurons in L2/3 are 
colored in gray. Thick lines represent dendrites. Axonal branches are depicted by thin 
lines and filled circles denote axonal boutons. (B) Post mortem fixed tissue slice 
stained with DAPI (blue). Green fluorescence reveals GCaMP6f-labeled neurons. 
Dashed lines indicate boundaries of the cortical layer. L1, layer 1; L2/3, layer 2/3; L4, 
layer 4; L5, layer 5; L6, layer 6. 
 
After 30-min exposure to CPA, we observed a small but significant 
reduction in the frequencies and amplitudes of spontaneous Ca2+ 
transients in axonal boutons (n= 92 boutons in 5 mice) (*p<0.05; 
Wilcoxon Signed-Rank test) (Figure 28C and Table 17). This effect was 
reversible upon wash-out of CPA (p>0.05; Wilcoxon Signed-Rank test). 
 
 
 
Figure 28. Intracellular Ca2+ stores influence the frequency and the amplitude of 
spontaneous Ca2+ transients in axonal boutons in PS45tg/tg mice. (A) Maximum 
intensity projection (21-25 µm below the dura, step 0.5 µm) of axonal segments and 
boutons in layer 1 of the motor cortex in a PS45tg/tg mouse. (B) Traces are 
spontaneous Ca2+ transients in axonal boutons recorded before, during, and after bath 
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application of CPA in axonal boutons marked with orange circles and respective 
numbers in (A). Note a decrease in the frequency of spontaneous Ca2+ transients in 
axonal boutons in the presence of CPA. (C) Box-and-whisker plots illustrating the 
median normalized frequencies and amplitudes of spontaneous Ca2+ transients in 
axonal boutons (n= 5 mice). CPA significantly decreased the frequency and amplitude 
of spontaneous Ca2+ transients (*p<0.05; Wilcoxon Singed-Rank test). This effect 
reverted upon wash-out of CPA (p>0.05 when compared to control condition; Wilcoxon 
Singed-Rank test). All values measured under CPA are normalized to their respective 
control values. A dashed help line is drawn at 100%. 
 
Table 17. Summary of the normalized frequency and amplitude of spontaneous Ca2+ 
transients of axonal boutons in PS45tg/tg mice. Data are presented as median  IQR. 
 
* Significantly different compared to their normalized values under control condition 
(100%) (p<0.05; Wilcoxon Signed-Rank test). 
 
We further investigated whether intracellular Ca2+ stores influence the 
patterns of spontaneous Ca2+ transients in axonal boutons. To this end, 
we classified Ca2+ transients in axonal boutons into two groups: single 
transients and bursts according to the criteria described in the method 
section (Figure 29A). Upon CPA treatment, we observed a significant 
reduction in the frequency of both single transients and bursts (*p<0.05; 
Wilcoxon Signed-Rank test), but this reduction was of a similar extent 
(p= 0.75; Mann-Whitney test) (Figure 29D and Table 17). Therefore, the 
relative fractions of single transients and bursts observed under CPA did 
not differ from those observed under control conditions (p>0.05 for both 
cases; Wilcoxon Signed-Rank test) (Figure 29B and C and Table 18). 
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Figure 29. Effect CPA on single transients and bursts in axonal boutons in 
PS45tg/tg mice. (A) Representative example of spontaneous Ca2+ transients in an 
axonal bouton. A dark gray box indicates a single transient and a light gray box 
indicates a burst. (B) Pie charts showing the relative proportion of single transients and 
bursts recorded before, during, and after bath application of CPA (n= 92 boutons in 5 
mice). Box-and-whisker plots illustrating the median normalized fraction (C) and 
frequency (D) of single transients and bursts of spontaneous Ca2+ transients in axonal 
boutons (n= 5 mice). The fractions of both firing patterns are not affected by CPA 
(p>0.05; Wilcoxon Signed-Rank test), while the frequencies of both firing patterns are 
significantly decreased in the presence of CPA (*p<0.05; Wilcoxon Singed-Rank test). 
 
Table 18. Summary of the normalized fraction and frequency of single transients and 
bursts in PS45tg/tg mice. Data are presented as median  IQR. 
 
* Significantly different compared to their normalized values under control condition 
(100%) (p<0.05; Wilcoxon Signed-Rank test).  
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From the obtained results, we concluded that the intracellular Ca2+ 
stores are involved in controlling Ca2+ transients in axonal boutons, but 
influence the generation of single transients and bursts in a similar 
manner. We have to mention, however, that in this experimental protocol 
the craniotomy was performed closed to the viral injection site. 
Therefore, we cannot exclude that CPA diffuses to layer 5/6 and partially 
depleted the intracellular Ca2+ stores in the somata of these cells. 
 
3.3.2.8   The contribution of presynaptic glutamate release on 
postsynaptic spontaneous neuronal activity in PS45 mice 
To investigate the contribution of presynaptic glutamate release on 
postsynaptic neuronal activity, the effect of activity-dependent 
irreversible NMDAR blocker MK-801 on spontaneous somatic Ca2+ 
transients was examined in PS45 mice. As we have not seen any 
difference neither in the basic properties of spontaneous Ca2+ transients 
in PS45tg/- and PS45tg/tg mice nor in their response to CPA, the 
experiments were performed in PS45tg/- mice only. In this protocol, 
spontaneous Ca2+ transients were monitored before and every 10 
minutes during topical application of 200 µM MK-801. To reach a 
plateau of the antagonistic effect, MK-801 was applied for a long period 
of time ( 2 hr). Following parameters were analyzed in these 
experiments: the maximum reduction of frequency, the time required to 
reach a half maximum reduction of frequency, and the amplitudes of 
spontaneous Ca2+ transients. 
As shown in Figure 30A, in the presence of MK-801 the frequency of 
spontaneous Ca2+ transients measured in normal and hyperactive cells 
gradually decreased and finally reached a plateau level. For analysis, 
we normalized all the recorded values to the respective control values in 
the absence of MK-801. There was a significant decrease in the 
frequency of either normal (n = 34 cells in 5 mice) or hyperactive cells 
(n= 20 cells in 5 mice, normalized frequency 6026% and 6023% for 
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normal and hyperactive cells, respectively, *p<0.05 for both cases; 
Wilcoxon Signed-Rank test) and the degree of reduction was similar for 
both cell types (p=0.92; Mann-Whitney test) (Figure 30B). Interestingly, 
the time required to reach a half maximum reduction of frequency was 
significantly shorter for hyperactive cells compared to that measured in 
normal cells (15.507 s versus 3012.75 s,*p=0.02; Mann-Whitney test) 
(Figure 30C). The amplitudes of spontaneous Ca2+ transients measured 
in both cell types were unaffected by MK-801 (p>0.05; Wilcoxon Signed-
Rank test) (Figure 30D). Our results suggest that the frequency of 
spontaneous Ca2+ transients measured in somata of layer 2/3 neurons 
in PS45tg/- mice depends on activation of postsynaptic NMDA receptors. 
Furthermore, postsynaptic NMDA receptors in hyperactive cells have 
higher open probability compared to that in normal cells, which is likely 
due to an increased presynaptic release probability of respective 
glutamatergic synapses. 
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Figure 30. Effect of MK-801 treatment on spontaneous Ca2+ transients in PS45tg/- 
mice. (A) Normalized frequency versus time plot showing the effect of bath-applied 
MK-801 in normal (green line; n= 34 cells in 5 mice) and hyperactive cells (red line; n= 
20 cells in 5 mice). Data are presented as meanSEM. Box-and-whisker plots showing 
the median maximum reduction in frequency (B), the time to half maximum reduction of 
frequency (C), and the amplitudes (D) of spontaneous Ca2+ transients in the presence 
of MK-801 (n= 5 mice). There is a significant reduction of frequency for both normal 
and hyperactive cells (*p<0.05 for both cases, Wilcoxon Signed-Rank test). The time to 
half maximum reduction of frequency measured in hyperactive cells is significantly 
shorter compared to that measured in normal cells (*p=0.02; Mann-Whitney test). The 
amplitudes of both normal and hyperactive cells are not affected by MK-801 (p>0.05; 
Wilcoxon Signed-Rank test). Dashed help lines are drawn at 100%. 
 
3.3.2.9   The role of intracellular Ca2+ stores for spontaneous  
dendritic Ca2+ signals in PS45 mice 
Next, we investigated how mutant PS1-mediated dysfunction of Ca2+ 
stores impacts spontaneous dendritic Ca2+ transients in PS45tg/- mice. 
To do so, we examined the effect of CPA on spontaneous Ca2+ 
transients in dendritic branches of layer 2/3 pyramidal neurons, which 
were loaded with a small molecule Ca2+ indicator OGB-1 by means of 
electroporation (see methods for further details). We first classified the 
recorded cell as normal or hyperactive by recording the spontaneous 
somatic Ca2+ transients. Then, we switched to recording of spontaneous 
Ca2+ transients in apical dendritic branches. The transients were 
monitored before, during, and after bath application of CPA, similar to 
the previous protocols (Figure 31A). Dendritic Ca2+ transients obtained 
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from paired branch recordings were categorized into local and 
synchronous transients according to the approach mentioned in the 
methods section (Figure 31B). 
After depletion of intracellular Ca2+ stores by CPA, there was a 
pronounced decrease in the frequency of spontaneous dendritic Ca2+ 
transients measured in either normal (n= 40 branches from 14 cells in 9 
mice, normalized frequency 618%, **p<0.01; Wilcoxon Signed-Rank 
test) or hyperactive cells (n= 34 branches from 14 cells in 9 mice, 
6024%, **p<0.01; Wilcoxon Signed-Rank test) and this decrease was 
of a similar extent (p=0.75, Mann-Whitney test) (Figure 31C). 
Interestingly, hyperactive cells also exhibited a significant reduction in 
the amplitudes of local and synchronous dendritic Ca2+ transients (n= 26 
branches from 9 cells in 6 mice, *p<0.05 for both cases; Wilcoxon 
Signed-Rank test). The reduction in the former was stronger than in the 
latter (*p=0.03; Mann-Whitney test). In normal cells, the amplitudes of 
local and synchronous dendritic Ca2+ transients were not affected by 
CPA (n= 30 branches from 10 cells in 6 mice, p>0.05 for both cases; 
Wilcoxon Signed-Rank test) (Figure 31D and Table 19).  To analyze the 
effect of CPA in more detail, we compared the fractions of local and 
synchronous dendritic Ca2+ transients across the three conditions. 
Surprisingly, there was a significant increase in the fraction of local 
dendritic Ca2+ transients and a proportional decrease in the fraction of 
synchronous dendritic Ca2+ transients measured in hyperactive cells 
(**p<0.01; Wilcoxon Signed-Rank test). The values obtained from 
normal cells exhibited similar trends, but these trends did not reach 
significance (p>0.05 for both cases; Wilcoxon Signed-Rank test) (Figure 
32A-B and Table 20).  
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Figure 31. Effect of CPA on spontaneous dendritic Ca2+ transients in PS45tg/- 
mice. (A) Traces are spontaneous dendritic Ca2+ transients recorded before, during, 
and after bath application of CPA. The colored dots indicate the type of neuron (green, 
normal and red, hyperactive cell). Note a decrease in the frequency of spontaneous 
dendritic Ca2+ transients measured in normal and hyperactive cells in the presence of 
CPA. (B) Left panel: Maximum intensity projection (153-157 µm below the dura, step 
0.5 µm) of apical dendritic branches of an electroporated pyramidal neuron. Orange 
boxes indicate regions chosen for simultaneous recording of spontaneous Ca2+ 
transients. Traces in the right panel are spontaneous dendritic Ca2+ transients 
recorded from dendritic branches marked with respective numbers in the left panel. 
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Gray boxes indicate synchronous spontaneous dendritic Ca2+ transients occurring in 
both branches at the same time. Purple boxes indicate local spontaneous dendritic 
Ca2+ transients occurring independently in one of the branches. (C) Box-and-whisker 
plots illustrating the distribution of median normalized frequency of spontaneous 
dendritic Ca2+ transients measured in normal and hyperactive cells (n= 9 mice). In the 
presence of CPA, there is a significant decrease in the frequency of spontaneous 
dendritic Ca2+ transients measured in both cell types (**p<0.01; Wilcoxon Signed-Rank 
test) and these decreases are similar for both cell types (p=0.75; Mann-Whitney test). 
(D) The distribution of median normalized amplitudes of local and synchronous 
dendritic Ca2+ transients measured in normal and hyperactive cells (n= 6 mice). In 
hyperactive cells, CPA significantly decreased the amplitudes of local and synchronous 
dendritic Ca2+ transients (*p<0.05; Wilcoxon Signed-Rank test). The reduction of 
amplitudes in the former was stronger than in the latter (*p=0.03; Mann-Whitney test). 
There was no change in the amplitudes of local and synchronous spontaneous 
dendritic Ca2+ transients measured in normal cells during CPA treatment (p>0.05; 
Wilcoxon Signed-Rank test). All values measured under CPA are normalized to their 
respective control values. Dashed help lines are drawn at 100%. 
 
Table 19. Summary of the normalized amplitude of local and synchronous dendritic 
Ca2+ transients of normal and hyperactive cells measured under CPA in PS45 tg/- mice. 
Data are presented as median  IQR. 
 
 
* Significantly different compared to their respective normalized values under control 
condition (100%) (p<0.05; Wilcoxon Signed-Rank test). 
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Figure 32. Intracellular Ca2+ stores influence the synchronization of spontaneous 
dendritic Ca2+ transients in PS45 tg/- mice. (A) Pie charts showing the relative 
proportion of local and synchronous dendritic Ca2+ transients measured in normal (n= 
30 branches from 10 cells in 6 mice) and hyperactive (n= 26 branches from 9 cells in 6 
mice) cells before, during and after CPA application. (B) Box-and-whisker plots 
showing the median fraction of local and synchronous dendritic Ca2+ transients 
measured in normal (n= 9 cells) and hyperactive (n= 9 cells) cells.  There is a 
significant increase in the fraction of local spontaneous Ca2+ transients of dendrites 
measured in hyperactive cells (**p< 0.01; Wilcoxon Signed-Rank test) during CPA 
application. The values obtained from the dendrites measured in normal cells show 
similar trends, but these results do not reach the level of significance (p>0.05 for both 
cases; Wilcoxon Signed-Rank test). ns = not significant.  
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Table 20. Summary of the fractions of local and synchronous dendritic Ca2+ transients 
measured in normal and hyperactive cells before, during, and after bath application of 
CPA in PS45 tg/- mice. Data are presented as median  IQR. 
 
** Significantly different compared to their respective values in control and wash-out 
conditions (p<0.01; Wilcoxon Signed-Rank test). 
 
Next, we compared the data obtained from dendritic recordings to those 
from the somatic recordings, obtained previously (see above) in the 
same mouse strain. As illustrated in Figure 33A-B and Table 21-22, 
under CPA the spontaneous Ca2+ transients of either somata or 
dendrites measured in normal and hyperactive cells exhibited a 
significant reduction of the frequency (*p<0.05 for all cases; Wilcoxon 
Signed-Rank test). Additionally, the amplitudes of the somatic and the 
dendritic Ca2+ transients measured in hyperactive cells were significantly 
smaller (*p<0.05 for all cases; Wilcoxon Signed-Rank test). In normal 
cells, CPA did not influence the amplitudes of neither somata nor 
dendrites (p>0.05 for all cases; Wilcoxon Signed-Rank test). The overall 
effect of CPA on the spontaneous Ca2+ transients in somata and 
dendrites measured in both cell types was similar to each other (p>0.05 
for all cases; Mann-Whitney test). 
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Figure 33. Intracellular Ca2+ stores are involved in controlling the spontaneous 
Ca2+ transients in both somata and dendrites in PS45tg/- mice. Box-and-whisker 
plots illustrating the distribution of median normalized frequencies (A) and amplitudes 
(B) of spontaneous Ca2+ transients of somata and dendrites measured in normal and 
hyperactive cells during CPA treatment in PS45 tg/- mice. Note that there is a significant 
reduction in the frequency of either somata or dendrites measured in normal and 
hyperactive cells (*p<0.05 for all cases; Wilcoxon Signed-Rank test) and the effects on 
somata and dendrites are similar to each other (p>0.05 for all cases; Mann-Whitney 
test). In hyperactive cells, CPA significantly decrease the amplitudes both in somata 
and in dendrites (*p<0.05 for all cases; Wilcoxon Signed-Rank test) and this reduction 
in the amplitudes is of a similar extent (p>0.05 for all cases; Mann-Whitney test). In 
normal cells, CPA does not influence the amplitudes neither in somata nor in dendrites 
(p>0.05 for all cases; Wilcoxon Signed-Rank test) and the effects are similar for soma 
and dendrites of both cell types (p>0.05 for all cases; Mann-Whitney test). All values 
measured under CPA are normalized to their respective control values. Dashed help 
lines are drawn at 100%.  ns= not significant. 
Results 
 
 
82 
 
Table 21. Summary of the normalized frequency of spontaneous Ca2+ transients of 
somata and dendrites measured in normal and hyperactive cells under CPA in PS45 tg/- 
mice. Data are presented as median  IQR. 
 
 
* Significantly different compared to their respective normalized values under control 
condition (100%) (p<0.05; Wilcoxon Signed-Rank test). 
 
Table 22. Summary of the normalized amplitude of spontaneous Ca2+ transients of 
somata and dendrites measured in normal and hyperactive cells under CPA in PS45 tg/- 
mice. Data are presented as median  IQR. 
 
 
* Significantly different compared to their respective normalized values under control 
condition (100%) (p<0.05; Wilcoxon Signed-Rank test). 
 
In summary, our data demonstrate that intracellular Ca2+ stores are 
involved in controlling the frequency and the synchronization of 
spontaneous dendritic Ca2+ transients. Additionally, the intracellular Ca2+ 
stores play a role in modulating the spontaneous activity of both somata 
and dendrites in a similar manner.  
 
83 
 
 
 
 
 
 
 
 
 
 
Chapter 4 
Discussion 
 
 
 
 
 
 
 
 
Discussion 
 
 
84 
 
4.1 Aging-mediated increase in neuronal hyperactivity 
The present study describes an alteration of ongoing spontaneous 
neuronal activity in the frontal cortex of aged mice. Using in vivo two-
photon Ca2+ imaging technique, we observed an increase in the 
neuronal activity in 10-14-month-old mice as suggested by a robust 
increase in the fraction of hyperactive cells compared to that in 6-10-
month-old animals. Interestingly, this result was observed not only in AD 
and PS45tg/- mice, but also in WT mice. On average, the fraction of 
hyperactive cells increased by approximately 20% in aged mice of all 
three strains, indicating that age progression aggravates neuronal 
hyperactivity. Obtained results provided additional evidence to support 
Khachaturian’s hypothesis that dysregulation of neuronal Ca2+ 
homeostasis is linked to brain aging in the first place [Khachaturian, 
1989]. A previous study using learning tasks with implanted electrodes 
in hippocampus has demonstrated an abnormal increase in firing rates 
of CA3 neurons in aged rats (25-27 months old) compared to young 
adult rats (6-8 months old). Interestingly, in aged rats these hyperactive 
neurons fail to encode new spatial information and cause a progressive 
memory impairment [Wilson et al., 2005]. A recent electrophysiological 
study in hippocampal slices has also shown that CA3 neurons in aged 
rats (29-32 months old) exhibit higher action potential firing rates and 
faster action potential repolarizations than CA3 neurons in young adult 
rats (2-5 months old). These results are mediated by enhanced 
expression of A-type potassium channels (Kv4.2/Kv4.30) [Simkin et al., 
2015]. Our results expand the above findings and show that aging-
mediated increase in neuronal hyperactivity is a widespread 
phenomenon which also affects neuronal network in the frontal cortex. 
Given the results obtained from three different mouse strains in this 
study, a common denominator is the aging processes. One can think 
about three possible mechanisms of aging-mediated increase in 
neuronal hyperactivity. The first possible explanation is a slight 
depolarization of the cell membrane. It is generally accepted that aging 
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is associated with an increased amount of oxidative stress and a 
progressive decline in the antioxidant defense [Zaidi, 2010]. The 
imbalance of these mechanisms leads to an excessive production of 
free radicals which damage various biomolecules such as lipids, 
proteins, and DNA [Uttara et al., 2009]. Age-related oxidative stress 
occurs in multiple organ systems, including the brain [Mattson, 2007; 
Supnet and Bezprozvanny, 2010]. The free radical-mediated lipid 
peroxidation of the neuronal membrane will eventually promote 
membrane-associated oxidative stress (MAOS). MAOS disrupts 
neuronal energy metabolism and ion homeostasis by impairing the 
function of ion- motive ATPases, glutamate and glucose transporters. 
These changes promote membrane depolarization and Ca2+ influx 
through NMDA receptors and VGCC which further increase the Ca2+ 
accumulation within neurons [Mattson MP, 2004, 2007; Stranahan and 
Mattson, 2012]. The second explanation is an increase in presynaptic 
spontaneous transmitter release. The perturbation in Ca2+ homeostasis, 
glucose or energy deprivation, and oxidative stress occurring in aged 
neurons can interfere with ER function and promote ER stress [Brown 
and Naidoo, 2012]. The result of a study using cultured hippocampal 
neurons has reported the impact of ER stress on synaptic transmission. 
The mentioned above depolarization-induced increase in [Ca2+]i as well 
as ER stress-mediated increase in Ca2+ sensitivity of the presynaptic 
spontaneous transmitter release machinery [Nosyreva and Kavalali, 
2010] increase the amount of neurotransmitter release from excitatory 
synapses. The third explanation is a low-grade inflammation-mediated 
neuronal excitability. The aging process in the brain also causes a 
dysregulation of the immune system which is characterized by 
immunosenescence and a chronic low-grade inflammation [Jurgens and 
Johnson, 2012; Gabuzda and Yankner, 2013; Deleide et al., 2015]. 
Studies in the brain of normal aged mice have illustrated an overall 
increase in the levels of proinflammatory cytokines, including interleukin-
1 beta (IL-1), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-
) [Godbout et al., 2005; Chen et al., 2008; Dugan et al., 2009; Baron et 
al., 2014]. Several studies have provided evidence for a link between 
Discussion 
 
 
86 
 
proinflammatory cytokines and neuronal excitability. For example, in a 
study on cultured hippocampal neurons, IL-1 increased NMDA receptor 
function through activation of tyrosine kinase 2 and subsequent NR2A/B 
subunit phosphorylation, thereby enhancing NMDA receptor-mediated 
Ca2+ influx [Viviani et al., 2003]. A more recent study using 
electrophysiological approaches reported that TNF- increases surface 
localization of NMDA receptor NR1 subunits [Wheeler et al., 2009]. 
Furthermore, TNF- preferentially increases synaptic expression of 
GluR2-lacking AMPA receptors. This is important as AMPA receptors 
lacking this subunit become permeable to Ca2+ [Jonas et al., 1994]. 
There is also evidence for a TNF--mediated increase in the frequency 
of spontaneous miniature postsynaptic currents in cultured hippocampal 
neurons [Grassi et al., 1994]. In addition, it has been reported that IL-1 
and TNF- impair the synaptic excitation-inhibition balance. One likely 
mechanism for this is a TNF-- or IL-1-mediated inhibition of astrocyte 
glutamate uptake [Hu et al., 2000; Ye et al., 1996]. Another possible 
mechanism is that TNF- causes an endocytosis of GABAA receptors 
[Stellwagen et al., 2005]. We incorporate these age-associated changes 
into a model of aging-mediated increase in neuronal hyperactivity 
(Figure 34). 
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Figure 34. A schematic drawing of the proposed mechanisms of aging-mediated 
increase in neuronal hyperactivity. MAOS, membrane-associated oxidative stress; 
ER, endoplasmic reticulum; IL-1, interleukin-1 beta; IL-6, interleukin-6; TNF-, tumor 
necrosis factor alpha; NMDA, N-methyl-D-aspartate; AMPA, -amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid; VGCC, voltage-gated Ca2+ channels.   
 
4.2   Enhanced caffeine-induced Ca2+ release from 
intracellular stores in amyloid-depositing mice 
We have first established a technique that enables the in vivo study of 
the function of intracellular Ca2+ stores. Using this new technique, our 
data revealed that application of RyR agonist caffeine results in a 
greater Ca2+ release from the intracellular stores in AD compared to WT 
mice. This statement is substantiated by the following findings: (i) a 
prolonged sustained phase of elevated [Ca2+]i, as indicated by increased 
T-half and tau of caffeine-induced Ca2+ transients, (ii) an increase in 
unitary caffeine-evoked responses, as suggested by the increased AUC 
ratio. We also observed a trend toward increased amplitude of caffeine-
induced Ca2+ transients in AD compared to WT mice, but this difference 
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did not reach the level of statistical significance (Figure 8). Considering 
responses of the three different cell types in AD mice (i.e. silent, normal, 
and hyperactive cells), the enhancement of caffeine-induced Ca2+ 
transients was most pronounced in hyperactive cells (Figure 10). Our 
findings confirmed and extended previous in vitro observations which 
reported exaggerated caffeine-induced Ca2+ signals in several AD 
models. Studies using primary neuronal cultures and acute brain slice 
preparations obtained from 3xTg AD mice and PS1-M146V KI mice 
have demonstrated large increases in caffeine-induced Ca2+ responses. 
[Chan et al., 2000; Smith et al., 2005; Stutzmann et al., 2006; 
Chakroborty et al., 2009; Zhang et al., 2010]. Similar alterations have 
also been observed in APPswe and APP695- expressing SH-SY5Y 
neuroblastoma cells [Oules et al., 2012]. Thus, our results reinforce the 
notion that aberrant Ca2+ signaling contribute to AD pathology and 
provide for the first time in vivo evidence for the dysregulation of ER 
Ca2+ homeostasis. 
Exacerbated caffeine-induced Ca2+ signals observed here could simply 
be due to an elevated ER Ca2+ accumulation. Indeed, our AD mouse 
model carries the PS1-G384A mutation which has been proposed to 
cause a disruption of the function of ER Ca2+ leak channels, thereby 
leading to overloaded ER Ca2+ stores [Tu et al., 2006; Nelson et al., 
2007]. Another possible explanation is an alteration in the function 
and/or expression of RyR in AD mice. Several studies have 
demonstrated an increase in RyR expression levels in different AD 
models and its link to APP and/or PS mutations. The previous studies 
reported that RyR isoform 3 is upregulated in mutant PS expressing 
PC12 cells, hippocampal neurons from PS1-M146V KI mice [Chan et al., 
2000], and cortical neurons from APPswe/ind mice [Supnet et al., 2006; 
Supnet et al., 2010]. Additionally, an upregulation of RyR isoform 2 has 
been reported in the hippocampal tissue of 3xTg AD mice [Chakroborty 
et al., 2009]. Based on our present findings and those of previous 
studies, we propose a mechanism accounting for an enhanced caffeine-
induced Ca2+ release from intracellular stores in the intact cerebral 
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cortex of AD mice (Figure 35). We hypothesize that the PS-mediated 
passive ER Ca2+ leakage in WT mice exhibits normal function and 
therefore provides the proper control of ER Ca2+ levels. In AD mice, the 
passive ER Ca2+ leakage is disrupted by PS mutation and thus ER Ca2+ 
levels are enhanced. Furthermore, the RyR expression is elevated in AD 
compared to WT mice, which leads to an enhanced amount of Ca2+ 
released in response to an agonist application. These mechanisms 
result in an exacerbated caffeine-induced Ca2+ signals in AD mice. 
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Figure 35. A proposed mechanism for an enhanced caffeine-induced Ca2+ 
release from intracellular stores in AD mice. (A) The PS-mediated passive ER Ca2+ 
leak channels in WT mice show normal function. These channels provide the proper 
control of ER Ca2+ levels. (B) In AD mice, the ER Ca2+ leak activity of PS is impaired, 
which in turn, leads to overloaded ER Ca2+ stores. Additionally, the RyR expression 
levels are upregulated. Therefore, the application of RyR agonist caffeine results in 
exacerbated caffeine-induced Ca2+ signals in AD compared to WT mice. Note the ER 
Ca2+ levels are represented by the blue area. Arrows indicate the direction of Ca2+ flux. 
ER, endoplasmic reticulum; RyR, ryanodine receptor; SERCA, sarcoplasmic / 
endoplasmic Ca2+-ATPase; PS, presenilin. Not all receptors are shown. 
 
The dysregulation of ER Ca2+ homeostasis may have a detrimental 
effect on neuronal survival and may contribute to AD pathology. It has 
been reported, for example, that overloaded ER Ca2+ stores enhance 
the vulnerability of cells to apoptosis [LaFerla, 2002]. The perturbation of 
ER Ca2+ signals disrupts protein folding and eventually leads to ER 
stress [Brown and Naidoo, 2012]. Additionally, an increase in ER Ca2+ 
release can further trigger increased A formation and increased 
hyperphosphorylated tau [Querfurth and Selkoe, 1994]. Furthermore, 
the synaptic dysfunction and cognitive deficits can be affected by 
aberrant ER Ca2+ signaling [Chakroborty et al., 2009; Peng et al., 2012; 
Oules et al., 2012]. 
 
4.3 NMDA receptor activation-mediated CICR in amyloid- 
depositing mice 
Our results reveal that in vivo NMDA-mediated Ca2+ entry triggers local 
Ca2+ release from intracellular Ca2+ stores in AD mice. This finding is 
consistent with previous in vitro studies which reported that the 
activation of NMDA receptors contributed to CICR in the acute brain 
slice preparations from 3xTg AD mice [Goussakov et al., 2010]. In our 
experiments, NMDA-mediated CICR is most profound in hyperactive 
cells compared to that in silent and normal cells (Figure 11). These data 
correlate with our observation that the pronounced response of caffeine-
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induced Ca2+ transients was also observed in hyperactive cells, 
indicating that in AD mice hyperactive cells exhibit a stronger overfilling 
of intracellular Ca2+ stores relative to silent and normal cells in AD mice. 
 
4.4  Store depletion normalizes pathological activity patterns 
in amyloid-depositing mice 
So far, the underlying causes of neuronal network hyperactivity in AD 
pathology are not entirely clear. It has been proposed that this 
phenomenon might be due to the direct effect of A species [Busche et 
al., 2008; Grienberger et al., 2012; Busche et al., 2012], the relative 
decrease in synaptic inhibition [Busche et al., 2008], and 
proinflammatory substances released from plaque-associated glial cells 
[review in Brawek and Garaschuk, 2014]. In this study, we demonstrate 
that emptying of intracellular Ca2+ stores though CPA treatment 
normalizes pathological activity patterns in AD mice (Figure 13). This is 
due to a remarkable decrease in the frequency of spontaneous somatic 
Ca2+ transients of both normal and hyperactive cells in AD, but not in 
WT mice. Among different cell types in AD mice, a reduction in the 
amplitudes of spontaneous somatic Ca2+ transients upon CPA treatment 
was observed only in hyperactive cells (Figure 14). This indicates that 
the contribution of Ca2+ release from intracellular stores to the 
amplitudes of spontaneous somatic Ca2+ transients is stronger in 
hyperactive cells than in normal cells. Thus, our results provide evidence 
that important mechanism underlying the neuronal network hyperactivity 
in AD mice may be related to Ca2+ release from intracellular stores. In 
WT mice, however, the neuronal network hyperactivity was insensitive to 
store depletion, suggesting that there may be another mechanism 
underlying this phenomenon. 
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4.5 PS1 mutation-mediated neuronal network hyperactivity  
We report here for the first time that the FAD-linked PS1 G384A 
mutation can cause the neuronal network hyperactivity in the frontal 
cortex of PS45 mice. We observed a striking increase in the fraction of 
hyperactive cells and a proportional decrease in the fraction of normal 
cells in 10-14-month-old PS45tg/- and PS45tg/tg mice when compared to 
age-matched WT mice (Figure 17). Interestingly, we found that the 
fractions of three cell types (silent, normal, and hyperactive cells), the 
frequency distributions, and the general features of spontaneous 
somatic Ca2+ transients were similar in both PS45tg/- and PS45tg/tg 
mouse strains (Figure 18). This suggests that the mutant PS1 gene 
dosage does not influence the frequency pattern and the characteristics 
of spontaneous somatic Ca2+ transients. The results of 
immunohistochemical stainings demonstrate that aged PS45tg/tg mice do 
not develop amyloid plaque depositions. Furthermore, there were 
neither signs of microglial activation nor reactive astrogliosis (Figure 15-
16), indicating that the neuronal hyperactivity in PS45 mice occurs 
independently of plaque formation and inflammation. We further 
investigated the effect of intracellular Ca2+ stores on neuronal network 
hyperactivity in PS45 mice. Under CPA, there was a pronounced 
decrease in the frequency, but not in the T-half and tau, of both normal 
and hyperactive cells. Additionally, a selective reduction in the 
amplitudes of spontaneous somatic Ca2+ transients was observed in 
hyperactive cells. Interestingly, blocking Ca2+ release from intracellular 
Ca2+ stores reduced hyperactivity of both PS45 strains in a similar 
manner to that observed in AD mice (Figure 21 and 22). Therefore, the 
PS1 G384A mutation alone is sufficient to mediate neuronal network 
hyperactivity. 
To investigate whether the PS mutation-mediated neuronal hyperactivity 
occurs in an age-specific manner, we extended our observation to 
young adult PS45tg/- mice at 6-7 months of age. Interestingly, the fraction 
of hyperactive cells in young adult PS45tg/- mice tended to be larger than 
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that in age-matched WT mice analyzed previously [Busche et al., 2008]. 
Hence, neuronal hyperactivity occurs already in young adult PS45tg/- 
mice. Furthermore, blocking Ca2+ release from intracellular stores 
reduced hyperactivity and normalized the neuronal network activity in 
young adult PS45tg/- mice. A reduction in the amplitudes of spontaneous 
somatic Ca2+ transients was observed in hyperactive cells, but not in 
normal cells (Figure 26). These findings are consistent with our results 
obtained in aged PS45tg/- mice, indicating that in PS45tg/- mice the 
intracellular Ca2+ stores are involved in controlling the frequency and 
amplitudes (in hyperactive cells) of spontaneous somatic Ca2+ transients 
in an age-independent manner. Surprisingly, different results were 
observed when we compared our findings in young adult PS45tg/- mice 
with a previous study [Grienberger et al., 2012] using a similar 
technique. Their results have shown that the fraction of hyperactive cells 
in the visual cortex in 8-10-month-old PS45 mice was similar to that in 
age-matched WT mice. The cause of this discrepancy remains 
unknown, but the different intracortical wiring in the visual and frontal 
cortex may be a contributing factor. 
When comparing general features of spontaneous somatic Ca2+ 
transients between young adult and aged PS45tg/- mice, we found that 
both normal and hyperactive cells in aged animals exhibited a delay in 
[Ca2+]i recovery as suggested by prolonged T-half and tau of 
spontaneous somatic Ca2+ transients (Figure 24). Generally, the 
duration of elevated [Ca2+]i following neuronal excitation is determined 
by the clearance of cytosolic Ca2+ and the capacity of cytosolic Ca2+ 
binding proteins, e.g. calmodulin and calbindin [Toescu and 
Verkhratsky, 2000]. We speculate that the prolonged spontaneous 
somatic Ca2+ transients in aged neurons might be related to the 
following mechanisms. First, an age-dependent decrease in the 
effectiveness of plasma membrane Ca2+ extrusion pathways like PMCA 
and NCX. Previous studies have demonstrated a decrease in PMCA 
pumping activity and the expression level of PMCA in aged rat brains. It 
has been proposed that a suppression of PMCA activity is associated 
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with conformational changes of PMCA induced by oxidative 
modifications [Zaidi et al., 1998; Zaidi and Michaelis, 1999; Zaidi, 2010; 
Zaidi et al., 2015]. A progressive decline in the effectiveness of 
calmodulin in stimulating PMCA activity has also been reported in aged 
rat brains. This effect is related to oxidative modifications of methionine 
residues leading to a loss of structural stability of calmodulin [Zaidi et al., 
1998; Gao et al., 1999]. Additionally, a decline of NCX activity due to a 
reduction in its affinity for Ca2+ transport has been observed in aged rats 
[Gomez-Villafuertes et al., 2007]. Second, the prolonged spontaneous 
Ca2+ transients may be caused by a reduction of cytoplasmic Ca2+ buffer 
capacity. Studies in aged rat brains have reported a reduction in the 
number of calbindin-immunoreactive neurons in several brain regions, 
including hippocampus and perirhinal cortex [Toescu and Verkhratsky, 
2000; Moyer et al., 2011]. Thus, an age-related decline in the function of 
PMCA and NCX together with a reduction in capacity of cytosolic Ca2+ 
binding may result in the prolonged decay phase of spontaneous 
somatic Ca2+ transients in aged PS45tg/- mice. 
 
4.6  The contribution of intracellular Ca2+ stores to pre- and 
postsynaptic Ca2+ signals in PS45 mice 
Our results prompted us to further investigate whether store-mediated 
neuronal network hyperactivity in PS45 mice is caused by pre- or 
postsynaptic mechanisms. The investigations of the presynaptic 
compartment provided two major evidences. First, our findings show a 
significant decrease in the frequency and amplitudes of spontaneous 
Ca2+ transients in axonal boutons in the presence of CPA (Figure 28 and 
29), implying that the presynaptic intracellular Ca2+ stores influence the 
transmitter release. This evidence is in close agreement with previous 
studies in the acute brain slice preparation and the hippocampal slice 
culture, which also demonstrated a role of presynaptic intracellular Ca2+ 
stores in modulating spontaneous and evoked transmitter release [Llano 
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et al., 2000; Bardo et al., 2002; Emptage et al., 2001; Simkus and 
Stricker, 2002; Galante and Marty, 2003]. However, we could only 
observe little effect on the distribution of single transients and burst, 
implying that the pattern of spontaneous Ca2+ transients in axonal 
boutons occurs independently of presynaptic intracellular Ca2+ stores. 
Second, we found a significant reduction in the frequency of 
spontaneous somatic Ca2+ transients of both normal and hyperactive 
cells during MK-801 treatment, indicating an influence of presynaptic 
glutamate release on the frequency of spontaneous somatic Ca2+ 
transients. Furthermore, the time required to reach a half maximum 
reduction of frequency was significantly shorter in hyperactive cells 
compared to normal cells. This result implies that the synapses on 
hyperactive cells exhibit higher open probability of the postsynaptic 
NMDA receptors than that in normal cells which is likely due to the 
higher probability of presynaptic glutamate release (Figure 30). 
The analyses of postsynaptic dendritic compartments provide the 
following conclusions. First, intracellular Ca2+ stores are involved in 
controlling the frequency of spontaneous dendritic Ca2+ transients in 
normal and hyperactive cells. This notion comes from the finding that the 
depletion of intracellular Ca2+ stores significantly reduced the frequency 
of spontaneous dendritic Ca2+ transients in normal and hyperactive cells 
(Figure 31A and B). Our results are consistent with previous studies in 
the CA1 region of rat hippocampal slice [Manita and Ross, 2009]. Their 
results described the role of Ca2+ release from intracellular stores in 
modulating the frequency of spontaneous Ca2+ events in dendritic 
branches in pyramidal neurons. Second, we observed a selective 
reduction in the amplitudes of local and synchronous dendritic Ca2+ 
transients in hyperactive cells, but not in normal cells, upon emptying of 
intracellular Ca2+ stores, indicating that the amplitudes of spontaneous 
dendritic Ca2+ transients in hyperactive cells are amplified by Ca2+ 
release from intracellular stores (Figure 31). Third, intracellular Ca2+ 
stores are at least in part responsible for the synchronization of 
spontaneous dendritic Ca2+ transients and this synchronization is slightly 
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more pronounced in hyperactive cells. Our findings are in agreement 
with previous studies in rat hippocampal slice which demonstrated that 
Ca2+ release from intracellular stores contributes to the propagation of 
Ca2+ transients in apical dendrites of pyramidal neurons. Additionally, 
the initiation of dendritic Ca2+ transients occurs at branch points where 
IP3R and RyR accumulated [Manita and Ross, 2009; Ross, 2012]. 
Based on this evidence, we assume that the synchronization of paired 
dendritic branches arises from the store-mediated propagation of 
spontaneous dendritic Ca2+ transients. Blocking Ca2+ release from 
intracellular stores leads to a reduction of the propagation which can be 
detected as an increase in the fraction of local transients and a 
proportional decrease in the fraction of synchronous transients (Figure 
32). 
 
4.7  Possible mechanisms underlying intracellular Ca2+ 
store-mediated neuronal hyperactivity in PS45 mice 
Based on the results of the present study, we propose a model to 
account for the neuronal network hyperactivity in PS45 mice. We 
hypothesize that the hyperactivity may be related to an increased 
probability of transmitter release from presynaptic terminals. In this 
model, an increase of Ca2+ liberation from presynaptic intracellular Ca2+ 
stores through RyR and IP3R causes an increase in [Ca2+]i, which in 
turn, triggers the fusion of synaptic vesicles with the plasma membrane 
of presynaptic terminals. This enhances the transmitter release and 
subsequently increases the frequency of postsynaptic Ca2+ transients. 
The emptying of intracellular Ca2+ stores with CPA reduces Ca2+ release 
from intracellular Ca2+ stores, thereby decreasing the [Ca2+]i in the 
presynaptic terminal. This decreases the synaptic vesicle release which 
eventually leads to a reduction in the frequency of postsynaptic 
spontaneous Ca2+ transients (Figure 36). 
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Figure 36. A propose mechanism for intracellular Ca2+ stores-mediated increase 
in a probability of transmitter release from presynaptic terminals in PS45 mice. 
Schematic illustration of the experimental condition under control (upper panel) and 
during CPA treatment (lower panel) in PS45 mice. Note the ER Ca2+ levels are 
represented by the blue area. Arrows indicate direction of ion flux. ER, endoplasmic 
reticulum; RyR, ryanodine receptor; IP3R, inositol triphosphate receptor; IP3, inositol 
1,4,5-trisphosphate; PIP2, phosphatidylinositol 4,5-bisphosphate; SERCA, 
sarcoplasmic / endoplasmic Ca2+-ATPase; NMDA, N-methyl-D-aspartate; AMPA, -
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; VGCC, voltage-gated Ca2+ 
channels; PLC, phospholipase C; SOCE, store-operated Ca2+ entry. Not all receptors 
are shown.  
 
Additionally, a decrease in transmitter release from presynaptic terminal 
likely also leads to a reduction in the amplitude of postsynaptic Ca2+ 
transients in hyperactive cells. Furthermore, a reduction in CICR in the 
postsynaptic compartment might contribute to the reduced amplitudes of 
postsynaptic Ca2+ transients as well as to the de-synchronization of 
postsynaptic Ca2+ transients between the dendritic branches.  
 
4.8 Clinical implications 
Several studies suggest the detrimental consequences of aberrant 
neuronal hyperactivity on neuronal network function. The first 
consequence would be a sustained increase of [Ca2+]i which can further 
activates protein phosphatase calcineurin [Kuchibhotla et al., 2008]. The 
excessive calcineurin activity has been proposed to cause dendritic 
degeneration, including dendritic beading and spine loss [Zeng et al., 
2007]. Second, the neuronal hyperactivity may contribute to behavioral 
and memory deficits. Studies using task-related functional magnetic 
resonance imaging (fMRI) have reported an involvement of hippocampal 
hyperactivity in performance deficits in patient with amnestic mild 
cognitive impairment (aMCI) [Bakker et al., 2012, Yassa et al., 2010]. 
Third, evidence from an fMRI study in nondemented aged human has 
shown that the hippocampal hyperactivity is associated with progressive 
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cortical atrophy [Putcha et al., 2011]. Fourth, there are several lines of 
evidence demonstrating the neuronal activity-dependent regulation of A 
secretion [Cirrito et al., 2005; Bero et al., 2011]. In rat hippocampal 
slices treated with A oligomers, the neuronal hyperactivity results in 
enhanced synaptic release of A and its oligomerization at synaptic sites 
[Deshpande et al., 2009]. This result is consistent with in vivo study in 
transgenic mice overexpressing APP with Swedish and Austrain 
mutation, which has shown that the optogenetically induced neuronal 
hyperactivity upregulates A production and increases A release from 
presynaptic terminals [Yamamoto et al., 2015]. 
A recent work using a new technology called chemogenetic approach 
which allows selective activation or inhibition of affected neurons has 
demonstrated that a chronic attenuation of neuronal hyperactivity in vivo 
reduces a degree of amyloid deposition and synaptic pathology 
associated with amyloid plaques in 5xFAD and APPswe/PS1deltaE9 mice 
[Yuan and Grutzendler, 2016]. Several studies raise the possibility that 
an attenuation of aberrant neuronal network hyperactivity might be a 
potential therapeutic for AD. Studies in patients and animal models have 
described an effect of an antiepileptic drug levetiracetam on neuronal 
hyperactivity. A treatment with low dose levetiracetam normalizes 
hippocampal hyperactivity and improves memory performance during a 
cognitive task in patient with aMCI [Bakker et al., 2012]. Furthermore, 
evidence from APPswe/ind mice has indicated that long-term treatment 
with levetiracetam reduces epileptiform activity, improves memory 
performance, and reverses synaptic deficits and plasticity [Sanchez et 
al., 2012]. Consistent with these findings, a protective effect of 
levetiracetam on behavioral deficits has been reported in 
APPswe/PS1deltaE9 mice [Shi et al., 2013]. In addition, a high dose 
treatment of valproic acid, an antiepileptic drug with Na+ channel 
blocking property, has been shown to reduce the frequency of 
epileptiform discharges in APPswe/PS1deltaE9 mice [Ziyatdinova et al., 
2011]. Another recent study has reported that an acute treatment with 
the -secretase inhibitor completely reverses neuronal hyperactivity and 
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reduces soluble A levels in APP23/PS45 mice [Busche et al., 2012]. 
Additionally, it was found that a genetic ablation of gene encoding tau in 
APPswe/ind mice normalizes neuronal hyperactivity, ameliorates the 
severity of the seizure phenotype, and prevents behavioral deficits 
[Roberson et al., 2007, 2011]. 
To date, the only available therapeutic for AD is symptomatic treatment 
which can temporarily ameliorate the symptoms and improve quality of 
life for patients [Selkoe, 2013]. There are two types of drugs which have 
been approved for AD treatment: acetylcholinesterase inhibitors and 
NMDA receptor agonists. However, there is no existing preventative and 
curative therapy that effectively reverses or stops AD progression. 
Current researches in AD drug development focus mainly on modulation 
of amyloid deposition, for example anti-amyloid aggregation agents, A 
immunotherapy, -secretase inhibitors, -secretase inhibitors, and -
secretase potentiation. Additionally, drugs interfering with tau deposition 
and anti-inflammatory agents have been identified [Selkoe, 2013; 
Yiannopoulou and Papageorgiou, 2013]. Our results reveal that blocking 
the Ca2+ release from intracellular stores through CPA treatment 
normalizes neuronal network hyperactivity associated with FAD-linked 
PS1 mutation. Therefore, we propose that normalizing Ca2+ release 
from ER might be an effective strategy to slow down pathological 
progression of AD. Although CPA has been approved for research 
purpose only, a RyR inhibitor dantrolene might be an attractive drug 
since it is approved by the Food and Drug Administration (FDA) for 
clinical treatment. Besides its potential therapeutic benefit for malignant 
hyperthermia and muscle spasticity, dantrolene also has a 
neuroprotective effect [Muehlschlegel and Sims, 2009; Liang and Wei, 
2015]. Recent works have reported beneficial effects of dantrolene 
treatment in AD mouse models. In vivo long-term dantrolene treatment 
(11 months) starting prior to the onset of amyloid deposition improves 
learning ability and decreases amyloid plaque burden in the 
hippocampus in 3xTg AD mice [Peng et al., 2012]. Chronic dantrolene 
treatment (3 months) also restores cognitive function in aged APPswe 
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mice. Additionally, dantrolene reduces a production of C99 fragment 
from APP and extracellular A load in primary cultured neurons isolated 
from APPswe mice [Oules et al., 2012]. Another study has described the 
beneficial effects of sub-chronically short term (4 weeks) dantrolene 
treatment. This short-term treatment regimen normalizes expression 
levels of RyR2 and restores synaptic transmission and plasticity 
homeostasis in 3xTg AD mice. In addition, the amyloid plaque 
deposition within the cortex and hippocampus is reduced in dantrolene-
treated APPswe/PS1-M146V mice [Chakrobotry et al., 2012]. 
 
Conclusion 
Our data reveal that the function of intracellular Ca2+ stores is altered in 
the intact cerebral cortex of AD mice as suggested by exacerbated RyR-
mediated Ca2+ release signals. Additionally, hyperactive cells in AD mice 
exhibit a stronger overfilling of their intracellular Ca2+ stores as indicated 
by a most pronounced CICR via NMDA-mediated Ca2+ influx. 
Furthermore, our study demonstrates an abnormal increase in neuronal 
hyperactivity in the frontal cortex in aged AD, PS45tg/-, and WT mice 
compared to that in young adult animals, implicating that age 
progression aggravates neuronal hyperactivity. As shown in store 
depletion experiments, this hyperactivity has a store-independent (in WT 
mice) as well as an additional store-dependent (in AD and PS45 mice) 
component. Consistently, the store depletion normalizes pathological 
activity patterns in amyloid-depositing mice. Obtained results from PS45 
mice provide the evidence that FAD-linked PS1 G384A mutation alone 
is sufficient to mediate neuronal hyperactivity. Interestingly, this 
phenomenon is independent of gene dosage, plaques formation, and 
inflammation, but rather dependent on Ca2+ release from intracellular 
Ca2+ stores. In addition, intracellular Ca2+ stores are critically involved in 
controlling the frequency of pre-and postsynaptic Ca2+ signals as well as 
the synchronization of spontaneous dendritic Ca2+ transients in PS45 
mice. This suggests the contribution of intracellular Ca2+ stores to 
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network-driven spontaneous Ca2+ transients. These results further 
strengthen the relevance of dysregulation of Ca2+ homeostasis in AD 
pathology. Thus, we propose that modulation of neuronal network 
hyperactivity by reducing Ca2+ release from intracellular Ca2+ stores may 
serve as a feasible therapeutic strategy for treating AD. 
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